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ABSTRACT
EXAMINING DEPRESSIVE SYMPTOMS OVER TIME IN WOMEN WITH CORONARY HEART DISEASE
Sydney A. Buckland, PhD
University of Nebraska Medical Center, 2019
Supervisor: Bunny Pozehl, APRN, PhD.

Coronary heart disease (CHD) is the number one killer of women in the US. Women also
experience roughly twice as much depression as men, and depression in CHD is associated with
increased morbidity and mortality. Despite these facts, women continue to be underrepresented in CHD research, and results by gender are not routinely reported.
Screening for depression in this population is problematic due to inconsistent inclusion of
somatic symptoms on screening instruments and disagreement about appropriate cutoff scores.
This body of work clarifies the concept of depression in women with CHD, presents a
systematic review of the longitudinal literature on depressive symptoms in women with CHD
examined by instrument, and presents results of a 3-month feasibility study examining women’s
depressive symptoms. The purpose of the study was to evaluate participant enrollment, data
collection, preliminary quantitative trends, and qualitative surveys for qualitative data
collection.
Participant recruitment by individuals other than the P.I. was generally poor and attrition
was problematic (16.7 – 28%). Prevalence of mean depression screening scores ≥ cutoff values
averaged 30% at baseline, 26% at month 2, and 25% at month 3. Trends in symptom severity
over the course of the study reflected trends in somatic symptoms and distress but not cognitive
symptoms. Current depression was strongly correlated with fatigue and sleep as well as younger
age, comorbid diabetes, a history of anxiety, and acute coronary syndrome symptoms. It was
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less strongly correlated with a history of depression and cardiac rehabilitation attendance. No
correlation was found between current depression and employment status. Qualitative survey
uptake was poor and the original survey was too restrictive, requiring modification.
This dissertation clarifies our understanding of the concept of depression in women with
CHD and summarizes the longitudinal descriptive literature on depression in women with CHD.
The dissertation study enhances our understanding of depressive symptoms experienced in this
population, gives some important preliminary data on use of the PROMIS Depression 8b
instrument in this population, highlights the importance of screening for depressive symptoms
in this population, and emphasizes the ongoing need for CHD studies which examine and report
data by gender.
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Chapter I.

Introduction

Numerous scientific articles have been published on the connection between mental health
and coronary heart disease (CHD), particularly depression. It is now well-established that the
development of depression following a cardiac event increases the risk of both morbidity and
mortality (Barth, Schumacher, & Herrmann-Lingen, 2004; Carney et al., 2009). In 2014, the
American Heart Association recommended that depression be elevated to the status of risk
factor for poor prognosis following acute coronary syndrome (Lichtman, 2014). Depression is
also now recognized as being a risk factor for the development of CHD (O’Neil et al., 2016), with
ongoing work exploring this connection from multiple perspectives, including possible genetic
linkages.
It is widely recognized that women are affected by depression at a rate of roughly 2:1
compared to men, starting at menarche and continuing until post-menopause. This 2:1 ratio is
true in both the general population as well as the CHD population. But as with other previous
heart disease research, examination of depression data by gender has not been routinely
undertaken and women continue to be under-represented in cardiac research. Studies which
have examined women separately have found that women and men do not always have the
same CHD experience. This includes symptoms of acute coronary syndrome, acute myocardial
infarction, and more recently there is evidence that women experience more microvascular
disease and stress-induced ischemia than men (Bairey Merz et al., 2006; Vaccarino et al., 2016).
The continued lack of women in CHD research, coupled with lack of data analysis by gender in
much of the published literature, has meant that even though women experience twice as much
depression as men, their depressive symptom experiences remain largely invisible.
The Concept of Depression in Women with CHD
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Research has demonstrated that women with CHD tend to experience more depressive
symptoms than men, both initially and over time (Buckland, Pozehl, & Yates, 2019), and women
tend to experience more “somatic” (physical) symptoms than men (Frazier et al., 2012; Grace,
Yee, Reid, & Stewart, 2014; Roest, Wardenaar, & de Jonge, 2016). However, the instruments
used to screen for depressive symptoms vary widely. While DSM-5, the Diagnostic and Statistical
Manual of Mental Disorders, fifth edition, defines the criteria for diagnosing depression and all
its subtypes, these screening instruments do not necessarily follow DSM criteria. Some, in fact,
do not include somatic symptoms at all. This, in effect, creates different operational definitions
of depression. This poses a significant challenge when using these instruments to screen for
depression in women in research studies as well as clinical settings.
Because of the lack of representation of women in heart disease research, and to highlight
the problems posed by the widely-varying depression screening instruments, the concept of
depression in women with CHD needs to be clarified. Chapter 2 of this dissertation looks at
depression in women with CHD as a concept, following the steps of concept analysis as
presented by Walker and Avant (Walker & Avant, 2011). Chapter 2, “Clarifying the concept of
depression in women with coronary heart disease,” was published ahead of print on March 7,
2019 in Advances in Nursing Science. The manuscript was co-authored by Dr. Bunny Pozehl,
current dissertation committee chair, and Dr. Bernice Yates, previous committee chair.
Depression in Women with CHD: State of the Science
Because depressive symptoms can and do last beyond the acute cardiac event and are
associated with worse outcomes, an understanding of what happens with depressive symptoms
in this population over time is important. Therefore, an examination of the longitudinal CHD
literature which included women, assessed depressive symptoms at more than one timepoint,
and reported and/or analyzed data by sex was performed. Chapter 3 of this dissertation reports
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the results of this systematic literature review, which also compared findings by depressive
screening instrument and, when possible, used prevalence data to compare findings since the
results of different screening instruments are not easily compared. Chapter 3, “Depressive
symptoms in women with coronary heart disease: a systematic review of the longitudinal
literature,” was submitted as a manuscript to the Journal of Cardiovascular Nursing. It was
accepted for prior-to-print publication as an open access article and appears in the
January/February 2019 issue. The manuscript was co-authored by Dr. Bunny Pozehl, current
dissertation committee chair, and Dr Bernice Yates, previous committee chair.
Results of a Mixed Methods Longitudinal Feasibility Study Examining Depressive Symptoms in
Women with Coronary Heart Disease
Given the problematic nature of using various different depressive screening
instruments in the CHD population, the lack of longitudinal data which examines women
specifically, as well as the difficulty in ascertaining the true nature of somatic symptoms which
overlap both CHD and depression, this author chose to explore the feasibility of conducting a
study to examine each of these components in women who had recently experienced a cardiac
event (acute coronary syndrome, myocardial infarction, percutaneous coronary intervention, or
coronary artery bypass graft). The research was guided by Lenz’ middle-range Theory of
Unpleasant Symptoms and was adapted to a conceptual framework of depressive symptoms in
women with coronary heart disease.
Specific Aims
The specific aims of this descriptive longitudinal mixed methods feasibility study were
comprised of both qualitative and quantitative aims, and are as follows:
Quantitative
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1. Evaluate participant enrollment, including recruitment strategies and efficiency, attrition at
each study timepoint, and enrollment and retention problems and solutions.
2. Evaluate data collection at each of the data collection time points of baseline, month 2, and
month 3, examining the use of REDCap vs paper, instrument reliability, the time required to
complete instruments, and the amount of missing data.
3. Evaluate data for preliminary trends in the following:
a. the prevalence of women who meet the cut-point criteria for elevated depressive
symptoms following a cardiac event at baseline, 2 months and 3 months post
study enrollment as measured by 3 commonly-used tools to measure depressive
symptoms and compare them to prevalence rates of elevated depressive
symptoms found in previous literature.
b. changes over time (baseline through month 3) in women's depressive symptom
dimensions (severity, quality, symptom distress).
c. the influence of CHD and depression on sleep, fatigue, and gastrointestinal
symptoms (loss of appetite, taste, and nausea) post cardiac event at baseline, 2,
and 3 months after study enrollment to estimate this effect size.
d. the influence of age, diabetes, employment status, attendance at cardiac
rehabilitation, a history of depression and/or anxiety, and concurrent acute
coronary syndrome (ACS) symptoms on depressive symptoms at baseline, 2
months, and 3 months after study enrollment in women post cardiac event.
Qualitative
4. Explore the acceptance and uptake of a qualitative survey as a qualitative data collection
method with a sub-sample of 10-15 women who agree to participate at baseline, 2, and 3
months post enrollment.
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a. Do the qualitative survey entries provide the type of data sought using the semistructured survey provided?
b. How many women indicated they would complete qualitative surveys vs how
many women actually completed these surveys at all 3 timepoints?
c. Describe how the qualitative data concurred with or differed from the
quantitative depression screening instrument scores?
A more detailed discussion of the study and its aims, as well as the study’s results and
conclusions will be presented in Chapter 4.
Significance and Impact
Heart disease is the leading cause of death among American women – 22.3% of all female
deaths in 2015 (https://www.cdc.gov/women/lcod/2015/race-ethnicity/index.htm). Depression
is one of the leading causes of disability in the US, affecting roughly 12 million women in the US
each year (Mental Health America, 2018), with women ages 40-59 being most affected (CDC,
2018). The cost of heart disease and depression combined is enormous - an estimated $410
billion per year in the US
(https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_disease.htm; Workplace
Mental Health, 2018). Women with CHD are more frequently affected by depression than men
but remain under-represented and understudied.
The cost of underdiagnosed women with CHD who also experience depression – in terms of
cost, lost productivity, and morbidity and mortality - is not trivial. We cannot afford to miss
women with CHD’s symptoms of depression. The concept analysis presented in this dissertation
identifies the defining attributes of depression in women with CHD so that those assessing this
population may choose instruments that assess these attributes. This is a critical first step in
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ensuring that women with CHD and depressive symptoms are correctly identified since we know
that those who have CHD and comorbid depression have poorer outcomes.
We also need a better understanding of what happens to women’s symptoms over time
so that we are able to identify those who are at risk of developing significant depressive
symptoms after their initial cardiac event or are at risk of having non-remitting symptoms. This
investigation provides a preliminary understanding of the relationship between symptom
dimensions as defined by Lenz - timing (here, changes over time), severity, quality (somatic vs
cognitive) and distress – as well as the relationship between depressive symptoms, specific
influencing factors, and somatic symptoms that overlap with CHD in order to help us to identify
these women.
With the new knowledge from these three manuscripts, more thorough assessment and
appropriate interventions for women may be developed, leading to less depression burden,
better outcomes, and ultimately less cost to the individual, community, and health care system.
Summary
In summary, the purpose of this dissertation is to explore depressive symptoms and
their dimensions in women with CHD over time, looking carefully at the instruments used to
assess depressive symptoms, the changes in prevalence of depression and its dimensions (as
define by Lenz) over time, and the somatic symptoms common to both CHD and depression.
This dissertation has been prepared following the 3-manuscript format as approved by
the advisory committee. As noted previously, Chapter 2 has been published in the Journal of
Cardiovascular Nursing, and Chapter 3 has been published ahead of print in Advances in Nursing
Science. Chapter 4 contains the manuscript of the dissertation research study results. Finally,
Chapter 5 contains an in-depth discussion of the conclusions of the study as well as implications
and suggestion for future research and practice.
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Chapter II.

Manuscript 1

Clarifying the concept of depression in women with coronary heart disease
*This is a non-final version of an article published in final form in Advances in Nursing Science:
https://journals.lww.com/advancesinnursingscience/pages/default.aspx

Background
Coronary heart disease (CHD) is the leading killer of women in the US, causing about 1 in
every 4 female deaths. And though heart disease mortality has declined significantly since its
peak in the 1950s, it has declined less in women. In the mid-1990s, the scientific community
began to explore the effects of depression on those with coronary heart disease. Approximately
12 million women in the US are diagnosed with depression every year, and 1 in every 8 women
will experience clinical depression in her lifetime. Research suggests that women experience
depression at a rate of 2:1 compared to men among those with CHD as well as in the general
population (Frazier et al., 2012).
Depression has significant health ramifications in the CHD population. In 2014, the
American Heart Association published a scientific statement elevating depression to the status
of risk factor for poor prognosis among patients with acute coronary syndrome (Lichtman et al.,
2014). There is strong evidence for increased negative outcomes among those who develop
depressive symptoms following a cardiac event, including increased morbidity and mortality
(Lichtman et al., 2014).
Evidence from work on acute coronary syndrome and acute myocardial infarction has
demonstrated that women and men do not necessarily have the same CHD experiences. In fact,
recent work has demonstrated that women experience more microvascular disease and stressinduced ischemia than men (Bairey Merz et al., 2006; Vaccarino et al., 2016). However, women
are under-represented in CHD research. The continued lack of women in CHD research, coupled
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with lack of data analysis by gender in much of the published literature, has meant that even
though women experience twice as much depression as men, their depressive symptom
experiences remain largely invisible.
While women’s depressive symptoms in this population have been explored, our review
of the literature suggests that limited research has been done to understand and clarify the
conceptual meaning of depression in women with CHD. From this review it appears that the
conceptualization of depression in women with CHD is widely variable, and that this variability
arises from the way the concept of depression is operationalized – i.e. the instruments used to
measure the concept. The literature search conducted for this paper yielded 16 different
instruments used to operationalize depression – from a 2-question screening instrument to the
gold standard Composite International Diagnostic Interview (see Table 1). Because different
instruments ask different questions and not all instruments include questions about certain
symptoms of depression (such has somatic symptoms), the actual concept of depression in
women with CHD may not be captured by the instrument being used to measure the concept.
Therefore, research on women with CHD and comorbid depression would benefit by a concept
analysis of depression in women with CHD.
Concept analysis, according to Walker and Avant (2011), is a “process of examining the
basic elements of a concept… result[ing] in a precise operational definition that by its very
nature increases the validity of the construct” (p. 158). Concept analysis can be used for various
purposes, including refining ambiguity of a concept in a theory, clarification of an overused or
vague concept, construction of a research instrument, or evaluation of existing research
instruments.
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Aims
The aim of this concept analysis of depression associated with a diagnosis of coronary
heart disease in women is concept clarification. Concept analysis for the purpose of concept
clarification is appropriate when a concept has a large body of literature defining and describing
it, including quantitative instruments for measuring the concept, but the concept is measured
using different variables and is applied inconsistently in the research (Morse, Hupcey, Mitcham,
& Lenz, 1996). Clarifying the concept of depression in women with coronary heart disease is
necessary for a better understanding of women’s experiences so that accurate diagnoses can
lead to more timely and appropriate interventions.
Design and Methods
This paper is organized according to Walker and Avant’s (2011) eight-step approach to
concept analysis: 1) selecting a concept; 2) determining the aim or purpose of the analysis; 3)
identifying all uses of the concept; 4) determining the concept’s defining attributes; 5)
identifying a model case; 6) identifying additional cases (borderline and contrary cases); 7)
identifying antecedents and consequences, and; 8) defining empirical referents.
To begin this concept analysis, the basic concept of depression was identified, aims
determined, and its use in both medical and non-medical settings explored. A literature search
from 1990 to August 15, 2018 of English language articles was then performed to explore the
concept of depression specifically in women with CHD. A PUBMED search utilizing the terms
coronary heart disease, depression, and sex factors or sex differences, with the filters female,
human, and English language yielded 100 articles. Because this concept analysis focuses
specifically on coronary heart disease (rather than the larger concept of cardiovascular disease),
articles related to heart failure, stroke, and peripheral vascular disease were removed. Articles
describing depression as a risk factor for the development of CHD were also excluded. After
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these exclusions, 40 articles remained. These articles were used to define the concept’s critical
attributes, antecedents, and consequences; cases were constructed using the concept; and
empirical referents identified. Finally, the use of this concept in future research and clinical
practice is discussed.
Uses of the Concept
The word “depression” has several different meanings and uses. Apart from its use in
common parlance, usually to indicate a low mood, it is also used in mathematics, astronomy,
meteorology, economics, and healthcare. Merriam-Webster’s online dictionary lists several
definitions: the angular distance of a celestial object below the horizon; the size of an angle of
depression; a pressing down, such as a depression of the tab key on a keyboard; a state of
feeling sad; a place or part that is lower than the surrounding area; a low, as in a tropical
depression, or; a long period of low general economic activity marked especially by rising levels
of unemployment.
The National Institutes of Mental Health (NIMH) gives this definition of depression:
“Depression (major depressive disorder or clinical depression) is a common but serious mood
disorder. It causes severe symptoms that affect how you feel, think, and handle daily activities,
such as sleeping, eating, or working. To be diagnosed with depression, the symptoms must be
present for at least two weeks”(Nation Institute of Mental Health, 2018).
Hare and Davis (1996), who created the Cardiac Depression Scale to assess for
depression in the cardiac population, used the DSM-4 (American Psychiatric Association, 1994)
criteria for “adjustment disorder with depressive symptoms” as their definition of depression.
According to DSM-4, “adjustment disorder with depressive symptoms” is defined as: “the
development of emotional or behavioral symptoms in response to an identifiable stressor(s)
occurring within 3 months of the onset of the stressor(s)”, creating distress in excess of what
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would typically be expected or significant impairment in social or work functioning. These
symptoms do not exceed 6 months in duration once the stressor is over.
The Diagnostic and Statistical Manual of Mental Disorders (DSM), published by the
American Psychiatric Association (APA), provides the medical diagnostic criteria for depression
as a mental health disorder. DSM-5, the most recent edition of the manual, lists eight different
diagnoses that fall under the category of depressive disorders: disruptive mood dysregulation
disorder, major depressive disorder, persistent depressive disorder (dysthymia), premenstrual
dysphoric disorder, substance/medication-induced depressive disorder, depressive disorder due
to another medical condition, other specified depressive disorder, and unspecified depressive
disorder. Though there are significantly different components to each of these eight diagnoses,
they all share common core features: sadness, emptiness, or irritable mood, accompanied by
somatic and cognitive changes that significantly impact an individual’s ability to function. Per
DSM-5 criteria, a diagnosis of major depressive disorder (MDD - the diagnosis most researchers
refer to when talking about depression in the CHD population) requires either depressed mood
or loss of interest or pleasure (anhedonia) plus 3-4 of the other 7 core symptoms (for a total of
at least 5 core symptoms) during a consecutive 2-week period. So-called “minor depression” (or
“depressive episode with insufficient symptoms”, defined under “other specified depressive
disorders” in DSM-5) requires only a depressed affect and 1 of the 8 other core symptoms of
MDD, with the same duration and distress or functional impairment as MDD to meet criteria.
More recently, Ormel and de Jonge (2011) developed an integrative model of
depression in the setting of CHD. Their model proposes two subtypes of depression: 1)
cognitive-affective (also called “typical”), characterized by depressed mood, anhedonia,
negative feelings such as self-dislike & sense of failure, guilt, interpersonal sensitivity, and future
pessimism; and 2) somatic/affective (also called “somatic”), characterized by fatigue,
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psychomotor agitation/retardation, sleep problems, aches and pains, appetite disturbance,
weight disturbance, and work difficulty.
These authors are interested specifically in depression in women following a diagnosis
of CHD (as opposed to depression as a precursor to its development). In the majority of studies
looking at depression in individuals with CHD, the authors do not provide a conceptual definition
of depression. Rather, depression is given an operational definition via the instrument used to
assess it. Confusingly, this leads to numerous different operational definitions.
Operational definitions.
The gold standard for evaluating patients for depression is the structured clinical
interview (American Psychiatric Association, 2018). However, such interviews are usually rather
lengthy (45 – 120 minutes) for research participants. Of the 40 articles reviewed for this paper,
only 2 used an interview to assess for depression. Therefore, most researchers rely on
instruments that screen for depression rather than completing a diagnostic interview, and cutoff
scores become a proxy for clinically significant depressive symptom burden. This makes these
screening instruments of paramount importance - the symptoms included on the screening
instrument become the operational definition of depression.
The instruments used to assess depressive symptoms in the CHD population can be
grouped into three categories based on the symptoms included/excluded and the origins of
their development: 1) instruments based on DSM criteria for depression that include somatic
symptoms, 2) instruments that do not include somatic symptoms, and 3) instruments based on
other criteria. Because of the multiple instruments used, three commonly used instruments will
be discussed as exemplars of the three categories. Table 1 lists all depression assessment
instruments found in the literature search, based on the above categories.
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Table II-1: Depression screening instruments found in the literature search
DSM* + somatic symptoms
No somatic symptoms
Non-Major Depressive
Disorder/Non-DSM* criteria
Beck Depression Inventory
Hospital Anxiety &
Zung Self-Rating Depression Scale
Depression Scale
Beck Depression Inventory-II
Patient Health
Geriatric depression scale
Questionnaire 2-item
Patient Health Questionnaire 9- Global Health
Hamilton Depression scale***
item
Questionnaire 30-item
Center for Epidemiologic Studies PROMIS Depression**
Gotland scale
Depression scale
Center for Epidemiologic Studies
Global Health Questionnaire 60Depression scale 8-item
item
EuroQuol-5D
Symptom CheckList 90
*Diagnostic

& Statistical Manual
not found in the literature search, but increasingly important in research
***Administered by a clinician, but not a diagnostic interview
**Instrument

Instruments based on DSM criteria that include somatic symptoms.
The first category of depression scales is those that were created based on the accepted
criteria for major depressive disorder (MDD) at the time of their creation and include both
cognitive and somatic symptoms. The best example of this is the Beck Depression Inventory
(BDI), originally published in 1961. Beck and his colleagues created a depression measurement
instrument by observing attitudes and symptoms displayed by depressed psychiatric inpatients
and outpatients at two hospitals in Philadelphia, consulting the newly-published Diagnostic and
Statistical Manual of Mental Disorders-I (DSM-I), and finally consolidating these observations
into a 21-item questionnaire (A. T. Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). The BDI-II,
an update to the original scale, was published in 1996 in response to the publications of DSM-3R and DSM-4 to make it more consistent with the current diagnostic criteria. Other scales found
in this review that are based on DSM criteria and include both cognitive and somatic symptoms
include the Center for Epidemiologic Studies Depression scale (CES-D) and its shorter version,
the CESD-8, and the Patient Health Questionnaire 9-item (PHQ-9).
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Instruments that do not include somatic symptoms.
The second category of scales measuring depression do not include somatic symptoms.
These were often developed to avoid measuring somatic symptoms that may have reflected
physical rather than mental illness. The hallmark example of this category of scales is the
Hospital Anxiety and Depression Scale (HADS). The HADS, developed by Zigmond and Snaith
from research conducted in general medical outpatient clinics and originally published in 1983,
focused on anhedonia as the central concept of depression. Zigmond and Snaith felt there was
no easy way to distinguish between physical symptoms rooted in a physical ailment and physical
symptoms reflective of a mental illness. They wanted an easy way to detect mental illness in
order to avoid a lengthy physical work-up. So Zigmond and Snaith created an instrument where
“…symptoms which might equally arise from somatic [physical] as from mental disease” were
excluded (Zigmond & Snaith, 1983). This concern about inclusion of somatic symptoms (such as
fatigue, changes in appetite, or sleep disturbance) measuring a physical rather than mental
illness, and subsequent overestimation of depression (Zigmond & Snaith, 1983) is echoed in the
more recently developed NIH-sponsored PROMIS depression instruments, which also do not
include any somatic depressive symptoms. Other assessment instruments, such as the PHQ-2
and the General Health Questionnaire 30-item, are shortened version of longer instruments
which have removed the somatic items.
Instruments based on other criteria.
The last category of depression scales is based on some criteria other than DSM MDD
criteria. The exemplar for this category is the Zung Self-Rating Depression Scale. Though DSM-I
had been published in 1952 it was not widely used until DSM-3 was published in 1980,
representing “a veritable paradigm shift in psychiatry” (Kawa & Giordano, 2012). The Zung scale
was created based on combining the results of three “factor analyses” (Zung, 1965). Three
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broad domains were identified - pervasive affect, physiological equivalents, and psychological
equivalents - and the most commonly-found characteristics in the factor analyses were fitted
into these domains and comprised the symptoms assessed by the scale. Subsequently, records
of interviews with patients were reviewed and statements which seemed most representative
of a particular symptom were chosen to create the scale. The final scale was a 20-item
questionnaire. Other examples of instruments in this category include the Geriatric Depression
Scale (based on the Research Diagnostic Criteria developed by the National Institutes of Mental
Health Psychobiology of Depression Collaborative Study, published in 1978), Gotland scale of
male depression (developed in 2002 with alcohol-dependent men, with questions about
irritability, aggression, and alcohol use) and the General Health Questionnaire 60-item
(developed in the 1970s for identifying minor psychiatric disorders in the general population),
among others.
The importance of “minor” depressive symptoms.
Strik and colleagues (2001) argue that the use of self-report depression scales to screen
for depression in clinical patients, such as those described above, are only justified if they
demonstrate high concurrent validity with DSM criteria for major and minor depression (italics
added). In a study examining the sensitivity and specificity of three frequently-used
questionnaires for depression in myocardial infarction (MI) patients, Strik et al. (2001) noted
that optimum cutoff scores (the score which combines maximal sensitivity with optimal
specificity on a receiver operating characteristics [ROC] curve) for MI patients are below the
generally accepted cutoff scores (which were determined using the population in which the
instrument was originally designed and tested). The generally accepted cutoff scores would
capture MDD but miss those with minor depression. Doering et al.’s (2006) study demonstrates
this perfectly. Of the 75 women in their study, seven (9.3%) met MDD criteria, while 20 (26.3%)
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met criteria for minor depression. Additionally, if women experience a preponderance of
somatic symptoms which are not captured on the depression scale being used, they will be
under-diagnosed or missed altogether. Ketterer and colleagues argued that there is a problem
with the DSM-4 threshold in patients with CHD in that it is too high and likely to overlook
patients with depression. That is, "…MDD criteria appear to exclude patients who are at risk for
adverse outcomes from CHD. . . . Furthermore, many other investigators have found 'minor'
depression to be predictive of CHD morbidity and mortality”(Ketterer et al., 2006, p. 53).
Defining Attributes
Walker and Avant (2011) describe the defining attributes of a concept as “a cluster of
attributes that are most frequently associated with the concept . . . [and] functions very much
like the criteria for making differential diagnoses in medicine” (p. 162). Several authors have
argued that individuals with heart disease, and women with CHD in particular, experience more
“somatic” symptoms than “cognitive” symptoms (de Miranda Azevedo, Roest, Hoen, & de
Jonge, 2014; Grace, Yee, Reid, & Stewart, 2014; Linke et al., 2009; Sanner, Frazier, & Udtha,
2013). Furthermore, low levels of depressive symptoms (i.e., fewer symptoms than required to
meet criteria for MDD) are not unusual in those with CHD and have also been associated with
worse outcomes such as increased all-cause and cardiac mortality (Lichtman et al., 2014).
Examining specific symptoms as attributes of this concept, several studies have
supported a group of symptoms as being the most common in women with CHD. These
symptoms include dysphoria/sadness; self-dislike; tiredness/fatigue; loss of energy; sleep
disturbances; appetite disturbances; concentration difficulties; indecisiveness; crying; and loss of
interest in sex (Doering et al., 2006; Frazier et al., 2012; Grace et al., 2014; Sanner et al., 2013).
Some of these symptoms are considered dimensions of the cognitive aspect of depression
(dysphoria/sadness, indecisiveness, crying, and self-dislike) and some of these symptoms are
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considered dimensions of the somatic aspect of depression (tiredness/fatigue, appetite
disturbance, loss of energy, sleep disturbance, and loss of interest in sex) (see Table 2). Frazier
et al. (2012) found that women had significantly higher scores than men on the following items
from Beck’s depression inventory: sadness, self-dislike, crying, indecisiveness, sleep disturbance,
appetite disturbance, and loss of interest in sex. Similarly, Grace and colleagues (2014), in
comparing men’s and women’s scores on the BDI-II and the Gotland Scale of Male Depression
(GSMD), found that women scored significantly higher than men on indecisiveness (BDI-II),
crying (BDI-II), tiredness (BDI-II), loss of energy (BDI-II), inexplicable tiredness (GMSD), sleep
problems (GSMD), changes in sleep patterns (BDI-II), loss of interest in sex (BDI-II),
concentration difficulty (BDI-II), and changes in appetite (BDI-II).
In addition to women scoring higher on depressive symptoms overall compared to men
in both studies, significantly more women in Frazier et al.’s (2012) study reported experiencing
somatic symptoms (sleep disturbance, appetite disturbance, and/or fatigue) than men, and in
Grace et al.’s (2014) study women scored significantly higher on the “psychomotor fatigue”
factor (“i.e. somatic features”) than men (p. 948).
The defining attributes delineated here must be present in any operationalized
definition of depression in women with CHD. In other words, the screening instruments used in
women with CHD must contain these attributes if we hope to adequately and accurately assess
this population.
Table II-2: Defining Attributes of depression in women with CHD
Cognitive symptoms
Somatic symptoms
Crying
Dysphoria/sadness
Indecisiveness
Self-dislike/poor self-esteem
Concentration difficulties
Hopelessness

Tiredness/Fatigue
Sleep disturbances
Appetite disturbances
Loss of interest in sex
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Model case
According to Walker and Avant(2011), a model case is one “that demonstrates all the
defining attributes of the concept” (p. 163); an exemplar. They may be found in the literature or
created for the purposes of the concept analysis. The following is a model case for depression in
women with CHD.
Marilyn is a 53-year-old divorced female with a personal history of poorlycontrolled type-II diabetes, hypertension, anxiety, and obesity who suffered an STelevation MI 2 weeks ago. She was treated with an emergent heart catheterization, and
two drug-eluting stents were placed at that time. Her father died of an MI at age 46, and
her mother had a stroke at age 65. She is now a caregiver for her mother, who resides
with her.
Marilyn has returned home from the hospital, but instead of feeling better she
finds she is now always tired and has little to no energy. Though she knows she should
be attending cardiac rehabilitation, she cannot bring herself to go. She is sleeping poorly
and is unable to concentrate on the things she needs to get done. She has no appetite
and forgets to eat. She has missed two weeks of work due to her heart attack, and
though she typically enjoyed her job, is now ambivalent about returning to work. She
often finds herself laying on her bed crying, wondering how she is supposed to “take
better care of herself”, care for her mother, and go back to work when she cannot even
get out of bed in the morning. She hates herself for not having managed her diabetes
better, getting so fat and out of shape, and now having heart disease on top of
everything else, and cannot imagine how she is ever going to manage.
This model case is a clear example of depression in a woman following a CHD diagnosis.
Additional Cases
Borderline case.
A borderline case will have some but not all of the defining attributes of the concept.
Marilyn is a 53-year-old divorced female with a personal history of poorlycontrolled type-II diabetes, hypertension, anxiety, and obesity who suffered an STelevation MI 2 weeks ago. She was treated with an emergent heart catheterization, and
two drug-eluting stents were placed at that time. Her father died of an MI at age 46, and
her mother had a stroke at age 65. She is now a caregiver for her mother, who resides
with her.
Marilyn has returned home from the hospital and remains fatigued with little
energy. She knows attending cardiac rehabilitation is important and though she is tired
she forces herself to attend anyway. She is less afraid of exercising than she was at first
and is sleeping better. Her appetite seems to be improving.
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She has missed two weeks of work due to her heart attack, and though she
typically enjoyed her job she is now ambivalent about returning. She is working hard at
trying to do what she is supposed to be doing (like eating better, checking her blood
sugars every morning, and remembering to take her medication every day) and take
care of her mother as well.
Contrary Case.
A contrary case would not display the defining attributes of the concept.
Marilyn is a 53-year-old divorced female with a personal history of poorlycontrolled type-II diabetes, hypertension, anxiety, and obesity who suffered an STelevation MI 2 weeks ago. She was treated with an emergent heart catheterization, and
two drug-eluting stents were placed at that time. Her father died of an MI at age 46, and
her mother had a stroke at age 65. She is now a caregiver for her mother, who resides
with her.
Marilyn has returned home from the hospital and has started attending cardiac
rehab. Though she still gets tired, she is feeling much better about how things are going
now. She is sleeping well and her appetite is back. She has missed two weeks of work
due to her heart attack and was initially apprehensive about returning, but now is
feeling more confident and is looking forward to returning once her doctor says it’s OK.
She has found that in focusing on taking better care of herself she has actually gotten
her mother to engage in some healthier choices and increased activity as well, making
these lifestyle changes easier to implement.
Antecedents
According to Walker and Avant (2011), antecedents of a concept “must occur or be in
place prior to the occurrence of the concept” (p. 167). Two antecedents to the concept of
depression in women with CHD are clear: (1) female gender and (2) a diagnosis of coronary
heart disease. It has long been recognized that women are at increased risk for depression
compared to men. Women experience depression at a rate of roughly 2:1, beginning at
menarche and continuing until menopause. The role of fluctuating levels of estrogen has been
hypothesized as explaining this difference, since women’s rates of depression begin to increase
just as hormonal fluctuation begins and decline once these fluctuations cease (Albert, 2015).
Women are also more vulnerable to depressive symptoms prior to menstruation, following
pregnancy, and during the perimenopausal period (Albert, 2015).
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Depression in the CHD population is even more common than in the general population.
Those who have had an MI experience depression at a rate of 17%-27% (vs 10%-29% in the
general population), and this rate is about twice as high in women with MI versus men
(Lichtman et al., 2014). The literature around depression in CHD also suggests that the
magnitude of the precipitating cardiac event or severity of the disease does not equate to the
emotional response (Doyle, McGee, Conroy, & Delaney, 2011). In other words, a minor heart
attack or only minor intervention does not mean a less dramatic emotional response. Likewise, a
major heart attack requiring a sizeable surgical intervention does not mean a more significant,
deeper depressive response.
Several other possible antecedents for this concept of depression have also been
described in the literature. These can be divided into two groups: physiological vulnerabilities,
including genetics, younger age, presence of angina, and comorbid diabetes; and psychosocial
vulnerabilities, including poor social support following a cardiac event, inability to return to work
following the cardiac event, and comorbid anxiety (see Table 3).
Physiological vulnerabilities.
Several authors have explored genetic vulnerability to depression in those with CHD
(Kendler, Gardner, Fiske, & Gatz, 2009; Liu et al., 2014; McCaffery et al., 2006). Though an
emerging area of scientific inquiry, these studies are beginning to elucidate a genetic link
between depression and CHD. McCaffery and colleagues (2006) cite several studies which
suggest a possible common genetic “substrate” between CHD and depression and propose
several candidate genes involving the inflammation and serotonin-mediated platelet
aggregation pathway. Liu and colleagues (2014), in examining seven possible single nucleotide
polymorphisms (SNPs) on the brain-derived neurotrophic factor (BDNF) gene, were able to
identify a single SNP which demonstrated a significant association with CHD-induced depression.
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A twin study performed from the Swedish twin registry done by Kendler and colleagues (2009)
found a moderately strong genetic correlation between major depression and CHD, which is
slightly higher in women than men (+0.67 vs +0.62, respectively).
Several studies have indicated that younger women with CHD appear more vulnerable
to developing depression than older women (Doering et al., 2006; Grace et al., 2005; Naqvi et
al., 2007). This may be due to younger women underestimating their risk for a cardiac event
(Doering et al., 2006), or greater difficulty in adjusting to the uncertainties of a future that now
includes a chronic illness in conjunction to the usual stressors of work and family roles (Grace et
al., 2005). Pre- and peri-menopausal women will also still be vulnerable to fluctuating levels of
hormones, as mentioned previously.
The presence of angina appears to be significantly associated with depression in those
with CHD (Jespersen, Abildstrom, Hvelplund, & Prescott, 2013; Portillo, White, Baisden, &
Dawson, 1995). Women, particularly American women, experience more angina than men
(Hemingway et al., 2008). Those who experience angina consistently scored higher on
depression assessment instruments than those who did not (Jespersen et al., 2013). Portillo et
al.’s study (1995) in Mexican-American women showed that more women with angina
experienced depression than women who did not have angina, and that this group also had
significantly more problems with functional impairment (which may in turn exacerbate
depressive symptoms). In Jespersen et al.’s (2013) study, angina was also significantly associated
with anxiety.
Comorbidity with diabetes has also been strongly connected to depression in women
with CHD in several studies (Annunziato et al., 2015; Kronish et al., 2006; Murphy et al., 2008).
Kronish et al. (2006), in their study of ACS patients, noted that women with CHD and comorbid
diabetes were more likely to report still being depressed 3 months after their cardiac incident
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than women without diabetes. Murphy et al.’s (2008) 12-month study of women after an acute
cardiac supports Kronish’s earlier finding of a link between higher incidence of depression in
women with comorbid diabetes. Annunzio et al.’s (2015) study found significantly elevated risk
of depression as well as suicidality in individuals with CHD and comorbid diabetes. Annunzio et
al. conclude that “it appears that having diabetes and CVD may be more concerning from a
[mental health] perspective than an MI” (p. 1282).
Psychosocial vulnerabilities.
Several psychosocial vulnerabilities have been identified in the literature regarding
women with CHD and depression. Poor social support as a risk factor for depression in women
following a cardiac event has been explored in several studies (Barefoot et al., 2000; Compare et
al., 2013b; ENRICHD, 2001). Barefoot et al.’s (2000) work examining the link between depression
and social support found that those with CHD and poor social support exhibited higher levels of
depression compared to those with good social support. Interestingly, social support seemed to
be a bigger factor in depression among younger patients with CHD than older patients. The
ENRICHD study, a groundbreaking study in the research of CHD and depression, found that over
1/3 (34%) of patients in the study experienced both depression and low perceived social
support, and these were predominantly women (ENRICHD, 2001). Compare et al.’s (2013a) tenyear literature review examining the relationship between social support and depression in CHD
patients (including marital relationships and social relationships) concluded that low levels of
social support is important risk factor for both development and worsening of depression.
Contrary to early hypotheses regarding work stress in women with CHD, research has
shown that women who are unable to return to gainful employment experience more
depression than those who are able to return to work (Blom et al., 2007; Boudrez & De Backer,
2000). Blom and colleagues (2007) examined 105 women of working age with CHD to determine

32
the association between work and depressive symptoms. They concluded that women who
were working demonstrated lower levels of depressive symptoms than those who were not,
regardless of age, educational status, or risk factors for CHD (including diabetes). Work also
increased the degree of social support experienced by these women. Boudrez and DeBacker
(2000) examined return to work in acute myocardial infarction or coronary artery bypass graft
patients. They found that, after one year, those who had returned to work demonstrated more
positive affect, less negative affect, and fewer somatic complaints.
Anxiety has been shown to have significant co-occurrence with depression in both the
general population as well as the CHD population and is a significant risk factor for developing
depression. Murphy and colleagues (2008) noted in their study which followed women for 12
months after a cardiac event that those who had anxiety were more likely to also have
depression than those who did not have anxiety. Doering and colleagues (2011), in their study
spanning three continents, found that women with CHD who experienced depression were 50%
more likely than men to report also having anxiety. Such is the degree of overlap that one of the
12 Research Planning Conferences prior to the publication of DSM-5 was dedicated entirely to
the “comorbidity of depression and generalized anxiety disorder” (Watson, 2009, p. 222).
Table II-3: Antecedents of depression
Female gender
Coronary heart disease diagnosis
Other possible antecedents to depression in women
Physiological vulnerability:
Psychosocial vulnerability:
• Genetic mechanisms
• Poor social support
• Younger age
• Inability to return to work
• Angina
• Comorbid anxiety
• Comorbid diabetes

Consequences
The consequences of both heart disease and depression in women are substantial. It has
been clearly demonstrated that individuals with CHD and comorbid depression have both
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increased morbidity and increased mortality compared to those without depression. “Among
women with MI or other forms of ischemic heart disease, depression is associated with an
approximate 3-fold increased risk for death or subsequent cardiac events independent of
severity of depression” (Mehta et al., 2016). Shah and colleagues (2014) found that depressed
women, ≤55 years of age, had substantially higher CHD comorbidity and worse prognosis. These
findings stress the need for more research on CHD and psychosocial factors, particularly
depression, in young women, who are often under-represented in clinical studies of
cardiovascular disease.
Women also experience significant alterations in role function, self-image, and selfmanagement, including secondary risk factor reduction (Kronish et al., 2006; Norris & King,
2009). Perhaps most important of these secondary risk reduction practices is exercise. Evidence
supports depressive symptom improvement with attendance at cardiac rehabilitation (CR),
regardless of the participant’s gender (Caulin-Glaser, Maciejewski, Snow, LaLonde, & Mazure,
2007). However, those with depression are less likely to attend CR, and less likely to complete
CR if they do attend initially.
Empirical Referents
Walker and Avant define empirical referents as “classes or categories of actual
phenomena that by their existence or presence demonstrate the occurrence of the concept
itself” (2011, p. 168). They are “a means by which you can recognize or measure [emphasis
added] the defining characteristics or attributes…” (Walker & Avant, 2011, pp. 168, italics
added). As has been discussed, the screening instruments to measure the presence or absence
of “depression” are not consistent in regard to which attributes are being measured, and prior
work calls into question how much of these attributes are required to be clinically significant in
this population. Therefore, these commonly-used instruments in conjunction with their
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standard cutoff criteria appear inadequate when it comes to measuring depression in women
with CHD.
Conclusions and Relevance to Clinical Practice
As previously stated, the purpose for this concept analysis was to clarify the concept of
depression in women following a diagnosis of CHD. A better understanding of women’s
experiences of depressive symptoms in this population will allow more accurate diagnoses to be
made and timely and appropriate interventions to be initiated. Based on this concept analysis, it
appears that depression in women with CHD has been operationalized as a somatic and
cognitive experience; only a cognitive experience; and as a pervasive affective, physical, and
psychological experience, among many others. This concept analysis has illustrated the need to
revisit these myriad operational definitions of depression as they pertain to this population in
order to be more congruent with the conceptual definition as defined by DSM-5. Based on the
literature reviewed for this analysis, women appear to experience both cognitive and somatic
depressive symptoms but be more burdened by somatic symptoms than men, and to experience
depressive symptoms at higher rates than men. Additionally, a specific group of symptoms (e.g.,
tiredness/fatigue, appetite disturbance, concentration difficulties, etc. - see Table 2) has been
identified as being the most common depressive symptoms in women with CHD. Further
qualitative studies which lend support to this group of symptoms as being the most commonlyexperienced and germane symptoms in this population is recommended.
Women with CHD who present with antecedent conditions, including a significant family
history of depression, younger age, angina, comorbid diabetes, poor social support, the inability
to return to work, or comorbid anxiety should be carefully monitored for the development of
depression as these conditions have clearly been identified with an increased risk of depression.
Women with CHD who present with somatic complaints need to be evaluated for possible
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depression, as these symptoms appear to be particularly salient to women’s depressive
experience and may also be perceived as “safer” to report given the stigma still associated with
mental illness by some (Grace, Yee, Reid, & Stewart, 2014). Screening for depression in women
with CHD is problematic due to the multiple instruments currently used to measure the concept.
Careful consideration should be given to the assessment instrument being used. If an
instrument with no somatic symptoms is chosen (such as HADS or PROMIS), some other means
of capturing these symptoms needs to be utilized and justification needs to be offered if the
instrument is being used for research purposes. When assessing this population, using MDD
criteria alone and excluding “minor” depression criteria to define who may need further
evaluation may not be appropriate since this criterion is likely to miss a significant percentage of
women who do in fact have depressive symptoms that may lead to worse outcomes.
Consideration should be given to using different cutoff scores on depressive symptom
assessment instruments, such as those proposed by Strik et al. (2001), Moullec et al. (2015), and
Haddad et al. (2013) when assessing this population.
Several instruments which were originally developed in non-cardiac populations have been
analyzed for use in the CHD population, including the Beck Depression Inventory I and II, the
PHQ-9, and HADS. Usually such analyses are performed to determine appropriateness for use in
the population and/or optimal cutoff scores for detecting clinically significant depressive
symptoms. However, these authors are unaware of any study which has compared the most
used and/or recommended depressive symptom screening instruments to a diagnostic interview
specifically in women with CHD to determine which instrument has the best Area Under the
Curve (indicating the best sensitivity/specificity for detecting depression in the population). This
is a significant gap in our ability to accurately assess women with CHD.
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However, thinking in the psychiatric community seem to be shifting away from the
previously-embraced “prescriptive” approach to diagnosis. The shortcomings of drawing hard
boundaries between mental health diagnoses and the significant overlap between such
conditions as anxiety and depression have forced what feels like another paradigm shift in
mental health. There is no clear consensus on the definition of depression. In a 2017 editorial,
Stringaris (2017) noted that “psychiatrists love to argue about [the definition of depression]. . . .
even two experienced practitioners would have a hard time agreeing on what depression is” (p.
1287). He notes the questionable coefficient  (a statistic of agreement between raters) for
adults in the DSM reliability field trials, situation-bound changes, the question of depressive
subtypes, and the concern of over-pathologizing normal low mood responses.
Still, it is undisputable that poor outcomes in women with CHD are associated with the
group of symptoms we currently call “depression”. The cost in terms of time and money, and
availability of resources for long diagnostic interviews will no doubt continue to prevent them
from being routinely used in research or primary care settings. Until such time as technology
(such as computer adaptive testing or artificial intelligence) makes screening instruments
obsolete and/or the very definition of depression is re-written, depression screening
instruments will continue to be used in both research and clinical settings. This analysis clarifies
the concept of depression in women with CHD and outlines its defining attributes along with its
antecedents and consequences. A model case, along with borderline and contrary cases, are
provided to make identification of this concept clear. In conclusion, as CHD research moves
forward researchers and clinicians need to be cognizant of utilizing instruments which
operationalize the concept of depression in women with CHD as presented in this concept
analysis.
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Chapter III.

Manuscript 2

Depressive Symptoms in Women with Coronary Heart Disease: A systematic
review of the longitudinal literature.
The role of sex/gender in coronary heart disease (CHD) has been extensively studied since
its importance was recognized in the 1980s (Lerner & Kannel, 1986; Wenger, 1985, 1990).
Similarly, the role of depression in CHD has been studied since the 1990s (de Miranda Azevedo,
Roest, Hoen, & de Jonge, 2014; Leung et al., 2012; Nicholson, Kuper, & Hemingway, 2006).
Depression is now recognized as a risk factor for poor outcomes in CHD (Barth, Schumacher, &
Herrmann-Lingen, 2004; Leung et al., 2012; Lichtman et al., 2014). Both CHD and depression
place a tremendous burden on women: CHD is the leading cause of death among women;
women have poorer outcomes following a cardiac event compared to men (Doering &
Eastwood, 2011; McSweeney et al., 2016); and women are affected by depression at a 2:1 rate
compared to men (Mazure, Keita, & Blehar, 2002; Shanmugasegaram, Russell, Kovacs, Stewart,
& Grace, 2012). Despite the frequent occurrence of both CHD and depression in women,
interpreting studies about women with heart disease and depressive symptoms is challenging
for several reasons. Women continue to be under-represented in research despite legislation
requiring their inclusion, making interpretation of studies with small numbers of women
problematic. Often data are not presented separately by sex/gender, so examination and
interpretation of women’s data apart from men’s is not possible. Many studies do not look at
depressive symptoms over time, leaving our understanding of what happens to women over
time incomplete. Finally, the use of multiple depressive symptom assessment instruments
makes comparisons between studies problematic.
This state of the science review examined depressive symptom data from longitudinal
studies of CHD which included women, collected depressive symptom data at more than one
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time-point, and reported and/or analyzed data by sex. When possible, studies were examined
by comparing the prevalence of elevated depressive symptoms (percentage of individuals
meeting cutoff criteria on assessment instruments) as different instruments’ results cannot be
easily compared. Studies were also examined based on which instrument was used. For the
purposes of this review, “sex” and “gender” were used interchangeably given the psychosocial
influences that “gender” – a social construct rather than a biological state – may confer in the
context of illness development and symptom experience.
Methods
Search Strategy
This literature review process
follows the PRISMA 2009
checklist (see Figure 1)(Moher,
Liberati, Tetzlaff, Altman, &
Prisma Group, 2009). A search of
databases including Medline via
PubMed, CINAHL, Embase, and
PsycInfo was performed on
February 1, 2016 and updated
April 26, 2018 for any recent
additions. Terms searched
included coronary artery
disease, coronary
arteriosclerosis, depression,
depressions, depression+,
Figure III-1: PRISMA Schema
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depression/exp, major depression, anaclitic depression, dysthymic disorder, endogenous
depression, postpartum depression, reactive depression, recurrent depression, treatment
resistant depression, and depressi*. Search limiters or filters included female, not male, English,
humans, adult: 19+ years, longitudinal, longitudinal study, peer reviewed, and 1990-2017.
Study selection
Because the exploration of the role of depression in CHD began in the 1990s, the year 1990
is used as a starting point for article inclusion. Journal articles were included if they met the
following criteria: the study examined ischemic CHD and had a descriptive, longitudinal design;
the study included women; depressive symptoms were assessed at more than one timepoint;
results were reported and/or analyzed by sex; and the article was published in a peer-reviewed
journal. This search retrieved 1,098 articles. Removal of duplicates left 723 articles. Articles were
then excluded for the following reasons: non-research articles (such as reviews); qualitative
articles; non-cardiac populations (such as diabetes); controlled trials (where an intervention may
have affected depressive symptoms); studies of other cardiac conditions (transplants, heart
failure, arrhythmia/pacer/ICDs, etc.); studies focused on risk for CHD; different phenomenon
within CHD (such as medications, biomarkers, or ST depression); populations known to have
high depression levels (abused women); or studies where minimal (i.e. one sentence)
examination or reporting of data by sex was performed. One-hundred thirteen full-text articles
were screened, and 28 hand-searched articles were identified and screened at that time. No
grey literature was searched. Twenty articles met inclusion criteria and were reviewed and
included in Appendix A.
Prevalence and cutoff criteria
When possible, studies were examined by comparing the prevalence of elevated depressive
symptoms. Prevalence is the proportion of a population affected by a certain condition. In the
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reviewed articles, prevalence was expressed as the percentage of participants meeting cutoff
criteria on the depressive symptom measurement instrument used by the author. Cutoff scores
are determined by receiver operating characteristic analysis (ROC), with the area under the
curve representing the score with the greatest sensitivity and specificity for correctly identifying
the presence of a condition. These scores are not diagnostic, but rather serve as a proxy for a
clinically significant level of impaired functioning in the individual.
Results
Prevalence of Depressive Symptoms
Prevalence in women at baseline.
Of the 20 studies that met inclusion criteria, only 8 provided prevalence data on women
participants separately from men (Caulin-Glaser, Maciejewski, Snow, LaLonde, & Mazure, 2007;
Doering, Magsarili, Howitt, & Cowan, 2006; Hunt-Shanks, Blanchard, & Reid, 2009; Josephson,
Casey, Waechter, Rosneck, & Hughes, 2006; Lavie, Milani, Cassidy, & Gilliland, 1999; Norris,
Hegadoren, & Pilote, 2007; Sanderson & Bittner, 2005; Shin, Hagerty, & Williams, 2010). The
prevalence of elevated depressive symptoms in women during hospitalization for an index
cardiac event ranged from 27.9% (Hunt-Shanks et al., 2009) to 40.3% (Norris et al., 2007), with a
calculated average of 35.75% across the 8 studies (see Figure 2). The studies which utilized the
Beck Depression Inventory-II (BDI-II) showed the highest prevalence: 38.8% and 40.3% in
patients with acute coronary syndrome (ACS) and myocardial infarction (MI), respectively
(Norris et al., 2007; Shin et al., 2010). The single study which used the Depression Interview and
Structured Hamilton (DISH) found a prevalence of 36% prior to hospital discharge (Doering et al.,
2006). A much lower prevalence of elevated depressive symptoms (27.9%) was found in the
study which utilized the Hospital Anxiety and Depression Scale (HADS) tool (Hunt-Shanks et al.,
2009). Two studies (Josephson et al., 2006; Sanderson & Bittner, 2005) used the measurement
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of depressive symptoms prior to beginning cardiac rehabilitation (typically 2-3 weeks after
hospital discharge) as the baseline time-point, though one additional study measured symptoms
at this time as a second measurement time-point - “post-discharge” (Doering et al., 2006).
Among these studies, the Beck instruments (BDI and BDI-II) demonstrated the highest
prevalence: 36% (Josephson et al., 2006) and 31%(Sanderson & Bittner, 2005) respectively. The
“post-discharge” study, which utilized the DISH, had a much lower prevalence of only 16.4%
(Doering et al., 2006).
Longitudinal prevalence among women.
Of the 20 studies which met inclusion criteria, only 5 provided prevalence data for more
than one time-point (Doering et al., 2006; Hunt-Shanks et al., 2009; Lavie et al., 1999; Norris et
al., 2007; Shin et al., 2010). The average prevalence of elevated depressive symptoms among
women across studies decreased from 35.75% during hospitalization to 27.8% 2-3 weeks postdischarge, to a calculated average of 22.71% over the next 24 months (see Figure 2). The trend
overall was for improvement in depressive symptoms through the first 6 months, with levelling
off between 6 to 24 months. However, one study demonstrated a small, statistically nonsignificant increase in prevalence from hospitalization (40.3%) to 12 months (40.4%) using the
BDI-II (Norris et al., 2007).
An examination of the available longitudinal data shows conflicting findings from
hospitalization to one month. Prevalence of elevated depressive symptoms dropped
significantly, from 36% to 16.4%, in a study (Doering et al., 2006) of post-CABG patients using
DISH, but only slightly (and statistically non-significantly) from 38.8% to 26.3% in a study of ACS
patients that used the BDI-II (Shin et al., 2010). A drop from 23% at 1 month to 12% at 4 months
post-hospitalization in women referred to CR was noted using the Kellner questionnaire (Lavie
et al., 1999). Doering at al.’s (Doering et al., 2006) study showed a nearly 3-fold drop in
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prevalence from 36% at hospitalization to 12.7% at 6 months using the DISH. Hunt-Shanks et
al.’s (Hunt-Shanks et al., 2009) study showed a smaller decline between hospitalization and 6
months: from 27.9% to 20.6% using the BDI. However, Hunt Shanks et al. (Hunt-Shanks et al.,
2009) reported a non-significant drop from 6 months (20.6%), to 19.2% at both 12 and 24
months. Norris et al.’s (Norris et al., 2007) study noted a small increase in prevalence from
40.3% during hospitalization to 40.4% at 12 months using BDI-II. No differences were noted
based on the year the study was conducted, despite significant changes to diagnostic and
treatment approaches over the intervening years (1999 – 2010).

Figure III-2: Prevalence of elevated depressive symptoms in women over time
Sex Differences
Prevalence in men vs women.
Five of the twenty studies reviewed provided prevalence data for both men and women
(Caulin-Glaser et al., 2007; Hunt-Shanks et al., 2009; Josephson et al., 2006; Norris et al., 2007;
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Shin et al., 2010). All five studies, regardless of assessment tool used, showed a higher baseline
prevalence of elevated depressive symptoms in women than in men, and all but one study (Shin
et al., 2010) also demonstrated a statistically significant difference between sexes (see Figure 3).
The average calculated baseline prevalence in men across these six studies was 23.46%, versus
34.8% in women. Of the depressive symptom assessment instruments used, the HADS showed
the lowest baseline prevalence in both men (18.7%) and women (27.9%)(Hunt-Shanks et al.,
2009). The highest prevalence for both sexes was found using the BDI-II: 32.7% in men and
40.3% in women (Norris et al., 2007). Three of the five studies provided prevalence data for
both sexes beyond baseline, (Hunt-Shanks et al., 2009; Norris et al., 2007; Shin et al., 2010) with
length of follow-up time ranging from 4 weeks (Shin et al., 2010) to 2 years (Hunt-Shanks et al.,
2009). All three studies showed a higher prevalence of elevated depressive symptoms among
women than men regardless of assessment tool used, though not all were statistically
significant. For both sexes, the HADS yielded the lowest prevalence, while BDI-II yielded the
highest prevalence.
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Figure III-3: Prevalence of elevated depressive symptoms – women vs. men
Non-prevalence findings in men and women at baseline.
Twelve of the 20 studies provided mean depressive symptom scores rather than prevalence
data (Barth et al., 2009; Bogg, Thornton, & Bundred, 2000; Brink, Grankvist, Karlson, & Hallberg,
2005; Duits et al., 1998; Grace et al., 2005; Grace, Grewal, Arthur, Abramson, & Stewart, 2008;
Gravely, 2007; Gupta, Sanderson, & Bittner, 2007; Lavie & Milani, 1995; McGrady, McGinnis,
Badenhop, Bentle, & Rajput, 2009; Phillips Bute et al., 2003; Zaninotto, Sacker, Breeze,
McMunn, & Steptoe, 2016). Of these studies, 1 measured baseline 2 weeks prior to CABG (Duits
et al., 1998), 7 measured baseline during hospitalization (Bogg et al., 2000; Brink et al., 2005;
Grace et al., 2005; Grace et al., 2008; Gupta et al., 2007; Phillips Bute et al., 2003; Zaninotto et
al., 2016), 3 measured baseline prior to CR (Barth et al., 2009; Lavie & Milani, 1995; McGrady et
al., 2009), and 1 measured baseline 45 days post-cardiac event (Gravely, 2007). Six studies (2
post-CABG studies and 4 post-CHD hospitalization studies) found women to have significantly
higher mean scores than men at baseline, regardless of instrument used (Duits et al., 1998;
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Grace et al., 2005; Gravely, 2007; McGrady et al., 2009; Phillips Bute et al., 2003; Zaninotto et
al., 2016). One study (Gupta et al., 2007) reported only a slightly lower mean score for men
compared to women on the BDI-II pre-CR. Three studies found no significant difference between
men and women at baseline post-MI (Brink et al., 2005; McGrady et al., 2009) or pre-CR (Barth
et al., 2009) using the HADS (Barth et al., 2009; Brink et al., 2005) and Kellner (McGrady et al.,
2009) questionnaires. Grace and colleagues (Grace et al., 2008) found no significant difference
between CR participants and non-participants at baseline in their all-female study using the
HADS. Brink et al. (2005) found women to have slightly (though statistically insignificantly) lower
levels of depressive symptoms than men at baseline using the HADS.
Non-prevalence findings in men and women after baseline.
Post-baseline timepoints ranged from 1 week (Duits et al., 1998) to 2 years (Zaninotto et al.,
2016). Over half of the studies found improvement in symptoms for both genders within 3-6
months following hospitalization, regardless of instrument used (Bogg et al., 2000; Duits et al.,
1998; Gravely, 2007; McGrady et al., 2009; Phillips Bute et al., 2003; Zaninotto et al., 2016). Two
studies had contrary findings: Brink and colleagues (Brink et al., 2005) found significantly
increased depressive symptom scores for both sexes between baseline and 5 months on the
HADS after a first-time MI; and Lavie and Milani (Lavie & Milani, 1995) found a significant
decrease in depressive symptom scores in men only following CR using the Kellner
questionnaire. For the remaining three studies, the measurement timeframe was much broader.
Philips Bute et al.’s (Phillips Bute et al., 2003) 12-month study using the Center for
Epidemiological Studies - Depression scale (CES-D) found statistically significantly higher levels of
depressive symptom both pre-CABG and 1 year post-op among women compared to men,
though both sexes also experienced significant improvements in depressive symptoms over the
1-year interval. Grace et al.’s (Grace et al., 2008) study found an improvement on the BDI at 18

54
months compared to baseline in women who had not participated in CR compared to women
who had. Zaninotto and colleagues (2016) found that among those who had experienced angina
or an MI in the past 2 years, women demonstrated a 13% higher probability of meeting cutoff
criteria compared to men both at baseline and at 2-year follow-up; this decreased to 5% at 4year follow-up using the CESD-8 (an abbreviated version of the CES-D containing only 8 items).
Discussion
This review of 20 longitudinal studies examining elevated depressive symptoms in
women with CHD yielded several important findings. It demonstrated that the prevalence of
elevated depressive symptoms among women at the time of CHD diagnosis was high, with a
calculated average of 35.75% – higher than men (23%), and higher than the commonly
perceived prevalence in the CHD population (20%), and this is true both at baseline and over
time. Prevalence varied by measurement instrument rather than participant inclusion criteria
(ACS, MI, PCI, general CHD), with the exception of CABG; this also held true over time. This
review also supported the perception that most women’s symptoms do improve, and that this
improvement largely occurs within the first 6 months after the index cardiac event.
However, the 20 articles summarized in this review varied widely in terms of timespan
covered (1 month - 2 years), and participant inclusion criteria. Prior research suggests that those
who have undergone CABG tend to experience fewer depressive symptoms than those who
have not, particularly compared to those who are medically managed after MI without
intervention (Pajak et al., 2013) or those with unstable angina (Geovanini et al., 2014; Lotufo et
al., 2013). Only two studies in this review focused exclusively on post-CABG patients. Of these,
only one provided prevalence data, and this was an all-woman study. Exclusion of this study
made little difference to the calculated average prevalence among women at hospitalization

55
(35.75% with the study, 35.66% without), but it did correlate to the lowest prevalence among
the studies at each of its follow-up timepoints (2-3 weeks, and 6 months).
Study follow-up timeframes may have also affected results. Due to the small number of
studies that examined symptoms beyond 6 months, the apparent improvement associated with
this timeframe may be a reflection of the paucity of longer studies rather than actual increased
improvement in this early stage of recovery. Stapelberg and colleagues (Stapelberg, Neumann,
Shum, McConnell, & Hamilton-Craig, 2013) indicated that one of the main gaps in understanding
the link between depression and CHD is failing to examine the follow-up timeframe. The authors
are not aware of any large studies where quantitative changes in severity of major depressive
disorder are followed at regular intervals over time. It is recommended that frequent measures
of patient mental state be correlated over time with measures of cardiac health to provide more
accurate longitudinal estimates of patient progress (Stapelberg et al., 2013).
The examination of prevalence data in this review demonstrated a difference in findings
based on instrument, with the BDI and BDI-II demonstrating much higher prevalence than the
HADS or Kellner questionnaire. A critical difference between instruments is the inclusion or
exclusion of somatic depressive symptoms (such as fatigue, alterations in sleep, or changes in
appetite). Instruments which included somatic symptoms yielded higher scores. Ormel and de
Jonge (Ormel & de Jonge, 2011) made a case for two different types of depression in CHD
patients: “typical depression” (characterized by vulnerability and stressful life events) and
“somatic depression” (triggered by “the presence of vascular disease, systemic inflammation
and atherosclerosis”). A study testing their integrative model supported their conclusion: those
with somatic depression were at risk for increased mortality (Roest, Wardenaar, & de Jonge,
2016). They noted that those with persistent somatic depressive symptoms were more likely to
be older women. The exception in this review regarding higher prevalence on instruments with
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somatic symptoms was the results for the DISH instrument. It detected a much lower prevalence
than the Beck instruments at baseline and pre-CR, and HADS at 6 months despite including
somatic symptoms. This may, however, reflect the CABG population it was used with rather than
its inclusion of somatic symptoms.
While it appears that there is a relationship between somatic symptoms and an increased
risk of mortality in CHD patients, it remains unclear if these somatic symptoms are depressive in
nature or are related to the underlying heart disease itself. Both depression and heart disease in
women can manifest as fatigue, sleep disturbances, and/or gastrointestinal symptoms such as
appetite changes (DeVon, Pettey, Vuckovic, Koenig, & McSweeney, 2016; Doering et al., 2006;
Kohlmann, Gierk, Hummelgen, Blankenberg, & Lowe, 2013; Sanner, Frazier, & Udtha, 2013). The
HADS tool deliberately does not contain questions about somatic symptoms since the authors
were concerned about confounding symptoms of physical illness with symptoms of depression
(Snaith & Zigmond, 1986). DeVon, who evaluated ACS patients using the HADS, stated that these
overlapping symptoms “confound [the] clinical picture” (DeVon et al., 2016). DeVon used the
HADS specifically because it does not measure physical symptoms which could be heart disease
rather than depression (DeVon, personal communication, October 14, 2016). Thus, while it
appears that these symptoms are significant and should be assessed, it remains unclear whether
they indicate depressive symptoms or rather reflect a physical disease process. Since
management will differ depending on the symptom’s source, further investigation of the source
of these somatic symptoms is warranted.
The reviewed studies also demonstrated the difficulty in trying to compare findings between
studies that use different measures of depressive symptoms. Use of item response theory and
the development of common metrics for assessing depressive symptoms as a means to generate
easily compare-able findings across studies has begun. PROMIS, a set of 90+ assessment
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instruments, was developed using item response theory and proposed as a common metric, but
the depressive symptom assessment instrument does not contain somatic symptoms.
Stapelberg and colleagues (Stapelberg et al., 2013) recommend a combination of interview and
DSM criteria-based self-report instruments to assess depression. This would facilitate a more
accurate diagnosis of major depressive disorder, increase accuracy in assessing symptom
severity, and potentially allow for a comparison between the two methods. Until an agreedupon common metric for measuring depressive symptoms is available, reporting prevalence
data either with or without an accompanying diagnostic interview will allow simple, direct
comparison between studies.
This review demonstrated that women continue to be under-represented in mixed-sex
studies of CHD, with women comprising an average of only 28.9% of study participants in this
review. The lack of data regarding women has been reflected in other reviews (McSweeney et
al., 2016). By not separating data by sex, the differences between men’s and women’s
symptoms continue to be obscured due to this underrepresentation. In order to understand
women’s unique experiences (and to create interventions which meet women’s needs), data
must be separately analyzed and reported by sex, a practice now expected by the National
Institutes of Health (2015). Ouyang and colleagues (Ouyang et al., 2016) also suggest
encouraging, if not requiring, data reporting by gender by both research sponsors and journal
editors.
While much has been learned over the past 30 years about women with heart disease and
comorbid depressive symptoms, this review highlights just how much remains unknown. Further
longitudinal studies and secondary analyses of existing longitudinal data which focus on sex
differences are needed to further elucidate women’s experiences and symptom trajectories.
The reporting of data by sex needs to become standard practice, particularly in light of the
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difficulty in recruiting equal numbers of women into clinical trials alongside NIH’s recognition of
sex as an important biological variable. While use of item response theory and the development
of common metrics for assessing depressive symptoms are underway, a simple
solution currently for reporting this data in a manner easily comparable is to report such data as
prevalence. These steps will provide a fuller picture of women with CHD and depressive
symptoms and allow development of more efficacious interventions for women.
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Chapter IV.

Manuscript 3

Results of a Mixed Methods Longitudinal Feasibility Study Examining Depressive
Symptoms in Women with Coronary Heart Disease
Introduction
Understanding the role of mood in the development of and in response to the diagnosis
of coronary heart disease (CHD) has been a significant advancement in our understanding of the
disease. It is now believed that mood, particularly depressed mood, plays a significant role in
outcomes following a cardiac event. Individuals who develop depression following a cardiac
event are at increased risk for morbidity and mortality (Lichtman et al., 2014). Evidence now
suggests that those who have depression are at increased risk of developing CHD as well (Kollia
et al., 2017; O’Neil et al., 2016). Women are known to have higher rates of depression
compared to men – approximately 2:1 - both in the general and the CHD populations (MollerLeimkuhler, 2008).
There is a wealth of literature examining the relationship between depressive symptoms
at the time of a cardiac event and both cardiac as well as all-cause outcomes. However, there is
far less literature examining the trajectory of depressive symptoms in patients over time
following a cardiac event. Even fewer studies examine data by gender and identify those who
have met cut-off criteria on the depressive screening instruments used in the study. Those
studies that examine gender have used a variety of depressive symptom screening tools making
it difficult to synthesize and draw conclusions from this literature.
Some studies suggest that somatic depressive symptoms are particularly prevalent
among women with CHD (Peter de Jonge et al., 2006; Roest, Wardenaar, & de Jonge, 2016).
However, the assessment of somatic depressive symptoms in the CHD population is problematic
since several of the most common symptoms overlap between the two diagnoses. Specifically,
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fatigue and sleep disturbances appear in both CHD and depressed patients, making their origin
difficult to ascertain. Several factors have also been noted to influence the development of
depressive symptoms in women with CHD. These include 1) age, 2) employment status, 3)
comorbidity with diabetes, 4) attendance at cardiac rehabilitation (CR), 5) a history of
depression, 6) a history of anxiety, and 7) acute coronary syndrome (ACS) symptoms (May Blom
et al., 2007; Caulin-Glaser, Maciejewski, Snow, LaLonde, & Mazure, 2007; Kohlmann, Gierk,
Hummelgen, Blankenberg, & Lowe, 2013; Kronish et al., 2006; Lesperance, Frasure-Smith, &
Talajic, 1996; Shah et al., 2014; Smolderen et al., 2015).
We know that some women who experience a cardiac event will experience significant
depressive symptoms at the time of the event, others will experience such symptoms later in
the recovery period, while others will not experience significant depressive symptoms at all. It is
not clear what accounts for the variability in prevalence of significant depressive symptom rates
at the time of the initial incident, the subsequent variability in recovery patterns, and the
differences in type of symptoms experienced. Two possibilities need to be considered: 1) the
way in which depressive symptoms are being measured, and 2) other factors influencing
depressive symptoms.
Materials and Methods
The purpose of this study was to examine the feasibility of conducting a study to
examine depressive symptoms in women ages 19 and over with CHD from the time of an index
cardiac event (defined as myocardial infarction ([MI], acute coronary syndrome [ACS],
percutaneous coronary intervention [PCI], or coronary artery bypass graft [CABG]) through the
first three months of recovery, exploring depressive symptom dimensions; incidence of
depressive symptoms; the influence of CHD and depression on sleep and fatigue; and the
influence of certain factors on depressive symptoms in this population.
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Theoretical Framework
This study was guided by Lenz’s middle-range Theory of Unpleasant Symptoms (Lenz,
Pugh, Milligan, Gift, & Suppe, 1997; Lenz, Suppe, Gift, Pugh, & Milligan, 1995). Lenz’s theory
proposes that three factors – physiological, situational, and psychological - influence symptoms.
Symptoms have four dimensions which are common across symptoms as well as clinical
populations. These four dimensions are intensity (or severity), timing, level of perceived distress,
and quality. Symptoms, in turn, influence performance (functional and cognitive activities). The
theory also posits reciprocal relationships between the theory’s components.
The examination of depressive symptoms in the CHD literature has largely been limited to the
dimension of severity, though a smaller body of literature has also explored quality (somatic vs
cognitive symptoms). For this study, a conceptual framework of depressive symptoms in
women with CHD was proposed, applying Lenz’s model to this population (see Figure IV1). Depressive
symptoms were defined as
“the presence of a sad,
empty, or
irritable mood” (American
Psychiatric Association,
1994) after
the cardiac event. Given that
symptoms change over
time as individuals adjust to
their new health
Figure IV-1: Conceptual framework of depressive symptoms in women with
coronary heart disease

status, timing was
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operationalized in months, beginning at the time of the cardiac event. Severity of symptoms was
determined by individual scores in relation to the tools’ cut-point score (which indicates
significant functional impairment). Quality was operationalized as either somatic (physical) or
cognitive symptoms. Symptom distress was determined utilizing the “Subjective Units of
Distress” scale. In this study, the relationship between all four individual depressive symptom
dimensions in women with CHD was explored, taking significant influencing factors (see Aim 4)
into consideration.
Specific Aims
The specific aims of the study were as follows:
Feasibility: Evaluate participant recruitment and retention, data collection (computer vs
paper, instrument reliability, time burden, missing data), and uptake and data quality of
qualitative surveys.
Quantitative: Evaluate data for preliminary trends in the following:
(1) the prevalence of women who meet the cut-point criteria for elevated depressive
symptoms following a cardiac event at baseline, 2 months and 3 months post study
enrolment as measured by 3 commonly-used tools to measure depressive symptoms,
comparing them to prevalence rates of elevated depressive symptoms found in previous
literature
(2) changes over time (baseline through month 3) in women's depressive symptom
dimensions (timing, severity, quality, symptom distress).
(3) the influence of CHD and depression on sleep and fatigue post cardiac event at baseline,
2, and 3 months.
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(4) the influence of age, diabetes, employment status, CR attendance, a history of
depression and/or anxiety, and ACS symptoms on depressive symptoms at baseline, 2
months, and 3 months.
Qualitative: Explore the acceptance, uptake, and quality of a qualitative survey as a data
collection method with a sub-sample of women who agree to participate at baseline, 2, and 3
months post enrolment.
Mixed methods: Describe how the qualitative data concurred with or differed from the
quantitative depression screening instrument scores.
Design
This study was a longitudinal, observational feasibility study using an embedded mixed
methods design. Both quantitative and qualitative data were collected simultaneously at each
point in the study, analysed separately, and combined at the end of the study. An embedded
mixed methods approach was chosen to provide a forum for women to discuss symptoms and
their dimensions that may not have been present on quantitative data collection instruments.
Institutional Review Board approval for conducting the study was obtained from the University
of Nebraska Medical Center (UNMC) (#567-17-EP) and Nebraska Methodist Hospital (#1372).
One regional hospital in a non-urban setting also served as a recruitment site under the UNMC
IRB. Inclusion and exclusion criteria were as follows:
Inclusion:
•

Female sex

•

age 19 + (the age of majority in Nebraska)

•

experienced a cardiac event (MI, ACS, PCI, or CABG) during the current hospitalization

•

cognitively intact, indicated by being able to describe what participation in the study will
involve
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Exclusion:
•

Diagnosis of chronic congestive heart failure (due to increased depressive symptoms in
this population) (Rutledge, Reis, Linke, Greenberg, & Mills, 2006)

•

Any orthopedic or neurological condition which limits day-to-day physical activity (since
these are known to limit women’s participation in cardiac rehabilitation, and nonparticipation is associated with greater depression) (Supervía et al., 2017)

•

CABG within the last 6 months

•

Pregnancy or planning to become pregnant in the next 6 months (due to both altered
physical and emotional responses during pregnancy) (Dolatian et al., 2016; Vogt et al.,
2014).

Sampling
Participants were recruited within one month of hospital admission via convenience
sampling from two urban and one regional Midwestern U.S. hospital. Women who met criteria
were identified by hospital staff and approached about study participation while in the hospital.
The study was explained and informed consent was obtained by the principal investigator (PI)
Buckland either face-to-face or via computer (in the case of the regional hospital). Baseline
quantitative surveys were either e-mailed or sent out via USPS once informed consent was
obtained. Data were collected again 2 months and 3 months after consent. Participants elected
to complete surveys on-line via REDCap (Research Electronic Data Capture) or on paper.
Qualitative surveys were used to collect qualitative data, and participation in this portion of the
study was optional. If participants elected to participate, they were asked to write for 15
minutes on 3 out of 7 days of the same week that they completed the quantitative surveys.
Semi-structured questions were provided. Surveys were returned to the PI along with the
quantitative surveys if submitted on paper, or via encrypted e-mail if done on the computer.
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Measures
Demographics:
Demographic information was obtained from each participant following consent. This
included age, race, level of education, employment, income, and marital status. Health history
questions, including what type of cardiac event the woman was hospitalized for, and any history
of diabetes, depression, or anxiety were also asked. Two demographics questions were asked at
the 2 and 3-month time points: employment (whether or not the woman had held a steady job
in the past month) and attendance at cardiac rehabilitation.
Depressive symptom measurement instruments:
Three depressive symptom measurement instruments were used in order to compare
prevalence findings: the Beck Depression Inventory II (BDI-II), the Patient Health Questionnaire
9-item (PHQ-9), and the Patient-Reported Outcomes Measurement Information System
Depression 8b (PROMIS Depression 8b). The BDI-II is a frequently-used instrument for assessing
depressive symptoms in the cardiac population and contains 21 cognitive and somatic items. It
has previously demonstrated an average Cronbach’s alpha coefficient of 0.9, test-retest
reliability of 0.73-0.96, concurrent validity with the Revised Hamilton Rating Scale for
Depression of 0.66-0.75, and discriminant validity with the Beck Anxiety Inventory of 0.56-0.69
(Wang & Gorenstein, 2013). BDI-II  20 is considered the typical cut-off value for this scale
(Beck, Steer, Ball, & Ranieri, 1996). Cut-off scores indicate the likely threshold for symptoms
creating interference in a person’s function.
The PHQ-9 was endorsed by the American Heart Association for use in assessing
depressive symptoms in cardiac patients (Lichtman et al., 2008), and also contains both
cognitive and somatic symptoms. It has demonstrated internal consistency with a Cronbach
alpha of 0.89, test-retest reliability of 0.84, and area under the curve of 0.95 in a receiver
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operating characteristics curve analysis for diagnosing major depressive disorder. PHQ-9  10 is
considered the typical cut-off value for this scale (Kroenke, Spitzer, & Williams, 2001).
The PROMIS set of assessment instruments was developed with prior funding from the
National Institutes of Health in order to be able to compare results of instruments across
multiple conditions (https://commonfund.nih.gov/promis/index). The PROMIS does not contain
somatic symptoms and has had minimal use in the cardiac population. It has previously
demonstrated reliability with a Cronbach alpha of 0.92, convergent validity with PHQ-9 of 0.72 –
0.81 (Pilkonis et al., 2014). Previous work suggests that instruments which do not include
somatic symptoms yield lower prevalence rates (Buckland, Pozehl, & Yates, 2019). Since cut-off
scores have not been established for the PROMIS tool, cut-offs based on Wahl et al.’s (2014)
calculations for a common metric among for 11 self-report depression assessment instruments
were used.
Distress instrument
Because distress is not measured as a component of any of the depression screening
instruments, the Subjective Units of Distress measure was chosen to measure this symptom
dimension. The Subjective Units of Distress scale is a 10-point scale where lower scores indicate
less symptom distress and higher scores indicate more symptom distress. The scales has
demonstrated correlations with the State/Trait Anxiety Inventory (r=0.72, p<.05) and with the
Multiple Affect Adjective Check List (MAACL) (r=0.59, p<.05) (Kaplan, Smith, & Coons, 1995)
Overlapping somatic symptom assessment instruments
Several symptoms of CHD and depression overlap, including fatigue and sleep
disturbance. Fatigue was assessed with the Fatigue Symptom Inventory (FSI), a 13-item
questionnaire which examines degree of fatigue as well as how much fatigue has interfered with
function. The FSI has demonstrated good reliability (0.93 in women, 0.95 in men) and
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convergent validity with the Profile Of Mood States (F=0.66-0.75) (Hann, Denniston, & Baker,
2000). Sleep was assessed with the PROMIS short form v.1 Sleep Disturbance 8b (PROMIS Sleep
8b), an 8-item scale assessing sleep disturbance. The PROMIS Sleep Disturbance 8b has
demonstrated reliability of 0.90 and convergent validity of .083 with Pittsburgh Sleep Index (Yu
et al., 2011). In order to ascertain whether the participant was experiencing ongoing acute
coronary symptoms as well, the Acute Coronary Syndrome (ACS) symptoms checklist was also
used. The ACS symptom checklist has demonstrated sensitivity of 14-72% and specificity of 3378% (DeVon, Rosenfeld, Steffen, & Daya, 2014).
Analysis
Quantitative: A fully powered study based on a priori power analysis using G*Power
3.1.9.2 and assuming a 10% attrition rate would have required 75 participants. A feasibility
study, according to the National Institute for Health Research, should be of a size “adequate to
estimate the critical parameters (e.g. recruitment rate) to the necessary degree of
precision” (Arain, Campbell, Cooper, & Lancaster, 2010, p. 4). Assuming that recruitment of
between ¼ and ⅓ of the total number for a fully-powered study would allow for adequate
estimation of critical parameters (recruitment rate, uptake of qualitative surveys, preliminary
data trends), 20 to 25 participants were deemed adequate for a feasibility study.
Quantitative data were analysed using IBM SPSS Statistics version 25. Descriptive
statistics were used for demographic data and mean scores. Paired T-tests were used to
examine differences in mean depressive symptoms scores between timepoints. Independent Ttests were used to examine differences in age based on whether or not the participant met cutpoint criteria on the depressive symptom screening instrument. The quality of depressive
symptoms – somatic vs cognitive – was determined by averaging scores of symptoms which
have been designated as somatic or cognitive by previous authors. Since the PROMIS instrument
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does not contain somatic items, it was not included. The BDI-II categories were based on
Thombs et al.’s (2010) article, which designates BDI-II items 1-14 as cognitive and 15-21 as
somatic. The PHQ-9 categories were based on de Jonge, Manago, & Whooley’s (2007) article
which identified questions 1, 2, 6, 7, and 9 as cognitive and questions 3, 4, 5, and 8 as somatic.
For all correlations, non-parametrics using Spearman’s rho were performed due to non-normal
distribution of the study data secondary to small sample size.
Qualitative: Women were asked to think about and write answers to the qualitative
survey questions on 3 of the 7 days of the same week in which they completed the quantitative
surveys. Qualitative data was sought in order to more fully explore women’s emotional
experiences following their cardiac event, particularly the four symptoms dimensions posited in
the theoretical framework (symptom severity, timing, quality, and level of perceived distress).
Terry and Braun (2017) recommend using thematic analysis for analyzing qualitative survey
data. The goal was to explore the views of participants as expressed in their own words as a
means of following the humanistic aim of empowerment (Jansen, 2010). Therefore, the
approach to the data analysis was inductive (“bottom-up”) rather than theoretical (“top-down”),
and the entire data set was analyzed rather than focusing solely on those pieces which explicitly
addressed questions regarding the four dimensions of the theoretical framework. The six phases
of thematic analysis as described by Braun and Clarke (2006) were followed. These are: a)
familiarizing yourself with your data, b) generating initial codes, c) searching for themes, d)
reviewing themes, e) defining and naming themes, and f) producing the report (Braun & Clarke,
2006).
Qualitative data was analysed using Atlas.ti 8 software. All journal entries were read in
their entirety, and then re-read. Quotations of interest were identified and assigned open codes
from the original text. Codes were then examined and grouped as initial themes were identified.
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These themes were reviewed once all coded text had been grouped, and final themes
subsequently named.
Mixed Methods: Women who participated in the qualitative portion of the study were
identified as having scored above or below the cut-point on any of the depression screening
instruments. The originally-identified quotations for each individual theme were then examined
based on the participant’s depression screening scores, looking for patterns in responses based
on these scores. The themes themselves were then divided based on differences noted between
women who had met cut-point criteria and women who had not, and quotations supporting the
differences were provided.
Results
Feasibility
Recruitment: Recruitment was problematic, due in part to issues of ethical access to the
population. Numerous staff members were approached about and agreed to recruit for the
study. However, only three of the nine individuals who agreed to recruit actually
Identified by staff as meeting basic inclusion criteria:
n=41

not consented:
n=19

CABG <6 months ago:
n=1

not interested in discussing
study with PI: n=3

consented: n=22

excluded due to >1
month past admission:
n=2
declined participation after
discussing with PI: n=5

given consent form but was never
returned to PI: n=8

Figure IV-2: Participant recruitment

did not return
baseline data
surveys: n=4
returned
baseline data:
n=18
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recruited participants using the original strategy. Inclusion criteria as well as postadmission timeframes were expanded in an effort to recruit more participants while still utilizing
the original recruitment strategy. A revised strategy for recruitment which required less of the
hospital staff’s time but required the PI to be at the bedside daily for participant recruitment
was finally implemented with significant improvement in recruitment rates. Details of
participant recruitment are provided in Figure IV-2.
Retention: Of the 22 women who signed a consent to participate, 18 returned the
baseline survey. At month 2, only 13 participants returned surveys. At both time points, the PI
called those who had not returned surveys up to two times and left messages along with the PI’s
contact information. At month 3, participants who had not returned their surveys within 1 week
of them being sent out were mailed a written reminder to return the surveys. This increased the
number who returned surveys to 15. This represents a 16.7% attrition from the original 18
participants who returned baseline surveys; or 31.82% from the initial 22 who signed consents.
Quantitative data collection: Participants were given a choice at the time of enrolment
to complete the study via REDCap, a secure HIPAA-compliant cloud-based application designed
to support data capture for research studies, or via paper. Of the 22 women who signed
consents, 50% chose to do the study on-line and 50% on paper. Of those who did not complete
the baseline data, again 50% chose on-line and 50% paper. Average data collection time (based
on on-line responses, which were time-stamped) showed that baseline data took an average of
17 minutes to complete, and months 2 and 3 took an average of 11 and 12 minutes respectively
to complete. There was very little missing data. Two individual data points from two different
participants were missing from PHQ-9. These values were substituted with the average scores of
the non-missing items (National Health Service, 2019). One participant did not complete the
PROMIS Depression 8b survey at baseline (though did complete the instrument at the other two
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data collection points). Because the on-line surveys required complete responses to move on to
the next survey, there was no incomplete data from REDCap.
Uptake and quality of qualitative surveys:
Participation in the qualitative portion of the study was
optional. Twelve women indicated that they would
participate, but only six returned baseline qualitative
surveys. This number dropped to three at month 2, and
remained at three for month 3. Only two women
provided qualitative survey data at all three timepoints,
with two more providing data at two timepoints. The
amount of data generated per participant varied
widely. Not all participants wrote for the 3 days
requested. Some responses were very short - 119 words
– and others much longer – 1,303 words. Because most
were hand-written, the survey reposes were dictated
into Word documents for improved readability and ease
of analysis.
Participant Characteristics
Women who participated in the study ranged in age
from 40 to 88 years old, with a median age of 6.
Participants were predominantly white (89%), married
(61.1%), with a high school education (44.4%). 47.1% of
participants reported an annual household income of

Table IV-1: Participant characteristics
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under $25,000/year, and 41.2% reported between $25,000 and $50,000 per year. 33% of the
sample had “held a steady job in the past 6 months” at baseline. Of the admitting cardiac
events, 27% of participants had been admitted for MI, 17% for unstable angina, 44% for PCI, and
11% for CABG. In terms of health history, 28% of participants reported a history of diabetes;
28% reported a history of depression; and 33% reported a history of anxiety. Of the four women
who signed consents but did not return baseline data, 2 had undergone PCI and 2 had
undergone CABG (see Table IV-1).
Quantitative Data Trends
Prevalence of Elevated Depressive Symptoms. The prevalence of women who met the
cut-point criteria for elevated depressive symptoms on the three depressive symptom screening
instruments (BDI-II, PHQ-9, and PROMIS Depression 8b) was evaluated. Mean scores at all
timepoints fell below the cut-off scores for each of the scales used. Over 20% of women scored
over the scales’ cut-offs at each timepoint (see Table IV-2). When comparing prevalence among
individual screening instruments, the PHQ-9 prevalence was an average of 9% lower than the
BDI-II, and 6.7% lower than the PROMIS despite its inclusion of somatic symptoms.
Changes over time in women's depressive symptom dimensions.
Severity: There were no statistically significant differences between severity of
depressive symptoms (as determined by mean scores at each timepoint) on any of the three
screening instruments at any timepoint. However, trends in changes were noted. Severity of
depressive symptoms appeared to decrease between baseline and month 2, and then increase
somewhat at month 3 on two of the three screening instruments (PHQ-9 & PROMIS) but
decrease at month 3 on one instrument (BDI-II) (see Table IV-2).
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Table IV-2: Depression mean scores and prevalence

Distress: There were no statistically significant differences between scores at any
timepoint, but again trends in changes were noted. The average value at baseline was 3 (2.80),
which decreased to 2.92 (2.56) at month 2, but then increased at month 3 to 3.2 (2.24).
Quality: There were no statistically significant differences between mean scores for
somatic and cognitive items on either the BDI-II or PHQ-9 at any timepoint. Trends in scores
demonstrated that the mean scores for somatic items were higher than those of cognitive
items. As with overall scale scores, mean somatic symptom scores decreased between baseline
and month 2, but then increased from month 2 to month 3. However, mean cognitive scores
decreased at each timepoint without an increase noted at month 3 (see Table 3).

Table IV-3: Mean cognitive and somatic depressive symptom scores

The influence of CHD and depression on sleep and fatigue. Given the small sample size
of the study, neither ANOVA nor effect sizes could be reliably calculated. Nonparametric
correlations using Spearman’s rho between CHD, depression (as measured by the three
depression screening instruments), and the identified somatic symptoms were performed and
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then compared. Because all women in the study had CHD, the ACS symptom scale was used as a
proxy for CHD. (See Tables IV-4 & IV-5 for correlation coefficients).

Table IV-4: Correlation (R) between fatigue severity & interference, depression scores, and CHD

Table IV-5: Correlation (R) between sleep, depression scores, and CHD

Depression screening scores demonstrated significant positive correlations with fatigue
(both severity and interference with function) and sleep. All fatigue severity and interference
scores at a given timepoint and the depression scores at the corresponding timepoint had
positive correlations significant at p<.005. Sleep scores at a given timepoint and the depression
scores at the corresponding timepoint had positive correlations significant at p<.005 for baseline
and month 3, and significant at p<.05 at month 2.
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ACS scores also demonstrated significant though slightly less robust positive correlations
with fatigue and sleep. All fatigue severity and interference scores at a given timepoint and
the ACS scores at the corresponding timepoint had positive correlations significant at p.05. All
sleep scores at a given timepoint and the ACS scores at the corresponding timepoint were
significantly positively correlated at p<.05.
The influence of demographic factors on depressive symptoms. Given the small sample
size of the study, ANOVA could not be reliably calculated. Therefore, simple correlations
between factors found to be significant in previous literature (age, diabetes, a history of
depression and/or anxiety, employment status, attendance at CR, and ACS symptoms) and
depression (as measured by the three depression screening instruments) were performed and
then compared (see Table IV-6 for correlation coefficients).
Age and Diabetes: There was a negative correlation significant at p<.05 noted between
age and depression scores at baseline and month 3, though not at month 2. A more granular
examination of the correlation between age and depression score found that the average ages
of those who met cut-off criteria on the three depression screening instruments at baseline
were 54.5 years (SD 14.1) for BDI-II; 46.3 years (SD 7.5) for PHQ-9; and 51.7 years (SD 12.2) for
PROMIS. The average age of those not depressed at baseline were 69.1 years (SD 13.3) for BDIII; 69.4 years (SD 12.8) for PHQ-9; and 70.9 years (SD 12.7) for PROMIS. Diabetes was found to
have significant (p<.05) positive correlation to depression at all timepoint on all screening
instruments except BDI-II at month 2.
History of depression or anxiety: Having a history of depression was found to be
significantly (p<.05) positively correlated with current depression screening scores baseline and
month 3 for all instruments except BDI-II at baseline. None demonstrated significant
correlations at month 2. A history of anxiety demonstrated stronger correlations to current
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depression screening scores, with significant (p<.05) positive correlations at all timepoints on all
instruments except BDI-II at
month 2.
Cardiac Rehabilitation
attendance, employment
status, and acute coronary
syndrome symptoms:
Depression scores at all
timepoints on all screening
instruments demonstrated a
significant (p<.05) negative
correlation to cardiac
rehabilitation (CR)
attendance at month 2, and
scores at baseline and
month 3 (but not month 2)
on all depression screening
instruments had a significant
(p<.05) negative correlation
to cardiac rehabilitation (CR)
Table IV-6: Correlations (R) between influencing factors, depression, and CHD

attendance at month 3.

Those whose depression screening scores were higher (meaning more depressive symptom
burden) were less likely to attend CR. ACS symptoms demonstrated a significant (p<.05) positive
correlation with depression screening scores on all instruments at all timepoints, though the 3-
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month depression screening scores demonstrated the strongest correlation to ACS symptoms at
any timepoint, reaching a significance of p<.005 on all three instruments. Employment status did
not show any significant correlation to depression screening scores at any timepoint, contrary to
previous literature.
Qualitative Data Findings
Three main themes were identified from the qualitative survey data: 1) health care
system interactions, 2) social engagement, and 3) individual response to the health event.
Women described experiences that negatively impacted their mood. First women felt angry or
upset because of poor interactions with their physicians.
06: “Dr. [X] hollers at me.”
06: “… the cold wind makes my chest hurt and has for several years. Doctor [X] says to
just live with it…”
14: “I think the very worst part of my heart problems is that doctors look at me like I’m a
menopausal woman who doesn’t know what I’m talking about. They make me feel fat
and lazy because there are so many things I used to love to do that I can’t do
anymore. The very worst thing is being lumped in and called a drug seeker! I have better
stuff at home - why the hell would I care about their drugs?”
The health care system was also a source of distress for women related to insurance and lack of
adequate coverage. Though she never states her frustration directly, one participant describes
more than one instance where poor insurance coverage prevented her from getting the care she
would otherwise have sought, such as secondary prevention.
06: “Heart Dr. wants me to do heart rehab exercise but I can’t. My insurance won’t pay.”
In another instance she experiences a frightening health-related episode and concludes,
06: “No I didn't go to the doctor - it was Saturday and ER would have run a million
dollars + tests and I have [name of insurance] that doesn't pay it all.”
Good relationships with care providers were also described that supported women’s emotional
well-being.
09: “Felt very relieved that the heart cath. went well because of my allergy to IV contrast
dye. Can thank Dr. [X] for his protocol that prevented a severe reaction.”
09: “I was so grateful for the excellent care I received in the hospital. I felt confident and
comfortable with Dr. [X] and Dr. [Y] doing the heart cath. and the angioplasty.”
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22: “It is an encouragement to me to have the coronary artery disease diagnosed and a
treatment plan begun. It was worrisome not to know for sure what was causing my
extreme fatigue.”
The second theme, identified was social engagement. Every woman in the study wrote
about how the level of social interaction affected her feelings. Several women noted that it was
in the moments when they were alone that they felt most down. Women valued contact with
family, but the a lack of family members close-by to created loneliness and isolation. Widowed
women found the absence of their spouse to exacerbate feelings of loneliness and isolation.
06: “I lost my husband in April, don’t have any ‘real’ friends to do things with so when I
come home from work its Blah.”
07: “Emotions –evenings are hard, my [late] husband and I always watched TV together
in the evenings. … [My sons] know evenings are my worst time, (alone) they call, and lift
my spirits.”
14: “I really miss my family and my best friend lives in [far away state] and the one sister
I'm closest to lives in [far away state] so we don't see each other all I can do is text
everybody.”
Social interaction with friends and family were described by women as “perking them up” and
lifted their mood.
06: “Got up in a good mood. 2 of my out of town friends called last night.”
11: “I did notice that my feeling + mood did change. I feel tired if I start worrying why
my children haven’t called. …So, I took time off, called a friend and asked her if she can
send her son to my house. He is nine years old. I have him help me put videos away or
organize them. He tells me about school, we go to the store, take a walk at the park.
And by the time I notice, [my worry] all goes away.”
09: “Over the course of the last several days, I have heard from lots of my friends… It
was great to hear from each and every one. Several, [names of friends], also came to
visit. Friends are real blessing.”
22: “Interacting with people usually perks me up and I forget the tiredness or get a boost
of energy.”
The last theme was individual response to the health event. These emotional responses
stemmed from women’s perceptions of their own health and whether it had significantly
changed. Changes were often described in terms of emotional responses to somatic and
cognitive symptoms. Disappointment was expressed over experiencing unexpected fatigue
following their cardiac event.
22: “I think I expected a significant improvement in my energy level after the stent was
put in place. While the shortness of breath has improved, I still feel the fatigue and this
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makes me consider the likelihood that I may not experience a return to full energy and
motivation.”
06: “Everyone says ‘Oh should feel better now.’ I didn’t feel bad before but now I seem to
have fatigue more – a lot more.”
Another participant lamented her loss of physical function.
14: “...there are so many things I used to love to do that I can’t do anymore.”
14: “I can't walk very far or very fast because of my heart and my hips”
More than one participant expressed anhedonia and problems with concentration or focus that
then led to depressed mood.
07: “I’m feeling more depressed than usual. I don't enjoy things like I used to.”
22: “I don’t care about anything” is the best way I can describe the mood and I would say
it has been significant.”
22: “I feel like my brain is wandering and I am having trouble with focus. Also, I feel very
fatigued and simply don’t want to do anything focused.”
Feeling “down”, self-dislike, and crying were also described.
14: “I don’t look in the mirror anymore. I don’t care for my body as much now.”
14: “I’m so used to feeling down I guess I don’t notice things as much.”
06: “I cry a lot – lonesome (?), Sad (?) don’t know –teary as I write now”
These experiences were not universal, however. Some participants felt that their cardiac event
did not have a significant impact on their emotions and denied any somatic or cognitive
symptoms.
09: “My general feelings remain positive with no depression at all.”
11: “I haven’t lost interest in doing activities, going places, and seeing people. I don’t
blame my mood or feelings on my heart disease. I blame them on situations or things
that occur.”
Mixed Methods Results
The purpose of conducting a mixed-methods analysis was to compare the qualitative
and quantitative data, looking for similarities and differences. Of particular interest was whether
women who met cut-off scores on depression screening tools provided substantively different
responses to women who did not. At baseline, four of the six women who provided qualitative
survey data met cut-off scores on at least one of the depression screening instruments. At
month 2, two of the three women met cut-off scores, and at month 3, one of the three women
met cut-off scores.
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Findings of the mixed methods analysis are summarized in Table IV-7. The theme health
care system interactions demonstrated a clear pattern based on depression screening scores.
Participants who scored below cut-off on depression screening instruments had positive
interactions with the health care system, and those whose depression screening scores were
above cut-offs had negative experiences with the health care system.
These results did not hold regarding social engagement. Women universally agreed that social
engagement lifted their mood, and that the times they were alone were more difficult
emotionally. The difference between women who did or did not meet cut-off criteria in this
category appeared to be two-fold: 1) the woman’s perceived availability of social contact, and 2)
the woman’s internal motivation to seek contact. Those who perceived less availability of social
contact had higher depression screening sores. Those who had more internal motivation for
seeking social contact had lower depression screening scores. One participant whose depression
screening scores were above cut-off values wrote frequently about social engagements, but also
frequently lamented about how alone she was. She did not write about seeking out contact.
Other participants who did not meet cut-off criteria on depression screening instruments wrote
about making themselves engage. One wrote, “I just have to get up and do something”. Another
stated, “I tend to push through it…”.
Finally, the theme individual response to the health event demonstrated mixed results.
Women who denied changes in their feelings due to the change in their health status all scored
below cut-off on depression screening. However, those who did report changes in feelings after
their cardiac event had depression screening scores both above and below cut-off values and
expressed experiencing both somatic and cognitive symptoms in their qualitative surveys.
Theme

1

health care

Depression
score ≥ or <
cutoff
< cutoff
•

Supporting qualitative data

“Felt very relieved that the heart cath went well because of
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system-level
interaction
•

•

≥ cutoff

•

•
•

2

social-level
< cutoff
engagement

•
•

•

≥ cutoff

•
•
•
•

my allergy to IV contrast dye. Can think Dr. [X] for his
protocol that prevented a severe reaction.”
“It is an encouragement to me to have the coronary artery
disease diagnosed and a treatment plan begun. It was
worrisome not to know for sure what was causing my
extreme fatigue.”
“I was so grateful for the excellent care are received in the
hospital. I felt confident and comfortable with Dr. [X] and
Dr. [Y] doing the heart cath and the angioplasty.”
“I think the very worst part of my heart problems is that
doctors look at me like I’m a menopausal woman who
doesn’t know what I’m talking about. They make me feel
fat and lazy because there are so many things I used to love
to do that I can’t do anymore. The very worst thing is being
lumped in and called a drug seeker! I have better stuff at
home - why the hell would I care about their drugs?”
“Dr. [X] hollers at me.”
“No I didn't go to the doctor - it was Saturday and ER would
have run a million dollars + tests and I have Humana that
doesn't pay it all.”
“Interacting with people usually perks me up and I forget
the tiredness or get a boost of energy”
“Over the course of the last several days, I have heard from
lots of my friends… It was great to hear from each and
every one. Several, [names of friends], also came to
visit. Friends are real blessing.”
“I did notice that my feeling + mood did change. I feel tired
if I start worrying why my children haven’t called. …So, I
took time off, called a friend and asked her if she can send
her son to my house. He is nine years old. I have
him help me put videos away or organize them.
He tells me about school, we go to the store, take a walk at
the park. And by the time I notice, [my worry] all goes
away.”
“I'm alone except for work. Sometimes the neighbor brings
food but not often. I go to church but nobody there checks
on me. Guess that's why I work - get out and see people.”
“Wally & I drove to Paxton to eat turkey dinner. He said I
needed to get outta town and it was nice.”
“I really miss my family and my best friend lives in New
York and the one sister I'm closest to lives in Ohio so we
don't see each other all I can do is text everybody.”
“I've been feeling very down lately...I feel like [my
husband] doesn't really care about my heart anymore. I do
what I can but he just doesn't get it. … He thinks this is just
a game I'm playing for attention. He’s also refused to take
me for counseling or cardiac rehab.”
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3

individuallevel
response to
the health
event

< cutoff
Unchanged

•
•

< cutoff
Changed
somatic

•

“I think I expected a significant improvement in my energy
level after the stent was put in place. While the shortness
of breath has improved, I still feel the fatigue and this
makes me consider the likelihood that I may not
experience a return to full energy and motivation.”

•

“I’m feeling more depressed than usual. I don't enjoy
things like I used to.”
“I don’t care about anything” is the best way I can describe
the mood…”
“I feel like my brain is wandering and I am having trouble
with focus. Also, I feel very fatigued and simply don’t want
to do anything focused.”
“Everyone says ‘Oh should feel better now.’ I didn’t feel
bad before but now I seem to have fatigue more – a lot
more.”
“I can’t walk very far because of my heart and my hips”
“I’ve been eating way too much to try and fill the hole I feel
inside.”

cognitive

•
•

≥ cutoff
somatic

“My general feelings remain positive with no depression at
all.”
“I haven’t lost interest in doing activities, going places, and
seeing people. I don’t blame my mood or feelings on my
heart disease. I blame them on situations or things that
occur.”

•
•
•

cognitive
•
•
•
•

“I cry a lot – lonesome (?), Sad (?) don’t know –teary as I
write now.”
“I worry a lot about the future”
“I’m so used to feeling down I guess I don’t notice things as
much.”
“I don’t look in the mirror anymore. I don’t care for my
body as much now.”
Table IV-7: Mixed Methods results

Discussion
This study provided important information about the feasibility of the utilized
recruitment strategies, retention strategies, and the use of qualitative surveys for qualitative
data collection, and adds important detail to our understanding of depressive symptoms in
women with CHD. When a future study is undertaken, a dedicated study recruiter will need to
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be identified and available on-site for participant recruitment. Anticipation of a 20-30% attrition
rate would be a more reasonable assumption given these initial results. Attrition after baseline
did not seem to improve with phone calls, but did with written reminders to return surveys.
Therefore, a plan to send written reminders to those who have not returned data may be a good
strategy to minimize attrition. The use of REDCap as a means of data collection was not a
significant improvement over paper in this population, though no missing data occurred with
use of REDCap. Continued use of both methods depending on participant preference appears to
be a reasonable strategy. Length of time to complete surveys was actually quite short,
demonstrating minimal participant burden.
These authors would make several changes to the approach used with qualitative
surveys as a method of qualitative data. First, more open-ended survey questions would be
beneficial so that women would feel more at liberty to write what came to mind about their
emotional experiences. Next, iterative revisions to the survey at each timepoint would help to
ensure that the desired information was being generated. Finally, the importance of following
through with qualitative surveys if the participant indicated they would participate should be
emphasized during the consenting process, perhaps attached to a larger incentive for the
participant given the poor return rate for qualitative surveys despite stated interest. The costs
and benefits of doing serial interviews with select participants should be weighed against this
less time-consuming but also less controllable (and, at least in this feasibility study, less reliable)
method of data collection.
The depressive screening instrument data from this study demonstrated prevalence
rates similar to previous studies. The average prevalence of depressive symptoms at baseline in
this study (30%) was slightly lower than the 36% found during hospitalization but slightly higher
than the 28% found at 2-3 weeks post-discharge in Buckland, Pozehl, & Yates’s (2019)
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systematic review of longitudinal literature on depressive symptoms in women with CHD. The
review found an average prevalence of 27% at 1 month, similar to the prevalence found in this
study at 2 months (26%). The 3-month prevalence in this study (25%) is far higher than the 12%
prevalence found at 4 months in the review (though this timepoint was represented by only 1
study).
A more granular examination of individual instruments yielded unexpected findings: the
BDI-II and PROMIS Depression 8b yielded more similar results than the BDI-II and PHQ-9, despite
the PROMIS not including somatic symptoms. This is in contrast to the finding of lower
prevalence among instrument which did not contain somatic symptoms in Buckland, Pozehl, &
Yates’ (2019) review.
Some authors have argued that including somatic symptoms on depression screening
instruments confuses the clinical picture and makes correct diagnosis more difficult (DeVon,
personal communication, 2014; (Snaith & Zigmond, 1986). Others point to these symptoms as
indicators of potential worse outcomes in CHD patients (de Miranda Azevedo, Roest, Hoen, & de
Jonge, 2014) or as a means of deciphering the underlying CHD from depression (McGuire,
Eastwood, Hays, Macabasco-O'Connell, & Doering, 2014). Given the performance of the PROMIS
Depression 8b in this study, this instrument may provide measures similar to somatic itemcontaining instruments. However, because of such small numbers of study participants this may
be more a reflection of a small sample than actual meaningful differences. A repeated
evaluation of these same measures in a larger sample size is needed.
The differences in depressive symptoms scores over time did not reach statistical
significance in this study, again likely due to the small sample size. However, severity of overall
depressive symptoms in this sample yielded an interesting trend. There was a trend toward
symptom improvement between baseline and month 2, with a worsening in symptoms at
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month 3 on two of the three instruments (PHQ-9 and PROMIS). This same trend was reflected in
the measure of distress as well. Even if the 3-month data from those who did not respond at
month 2 are removed, the mean scores on PHQ-9 and PROMIS remained higher at month 3 than
month 2. Interestingly, this trend seemed to reflect the changes in somatic depressive
symptoms but not cognitive symptoms, which continued to decrease across all time points.
Somatic symptom scores were higher than cognitive scores in this study, supporting the idea
that somatic symptoms in women are of particular importance. These differences and
depressive symptom trends should be interpreted with caution and would need to be validated
in a larger sample.
The significant overlap between the somatic symptoms of sleep disturbance and fatigue
was examined in this feasibility study. This preliminary examination of these symptoms
demonstrated that there was a significant correlation between the depressive screening scores
and both fatigue and sleep. This is consistent with previous findings (Doering & Eastwood, 2011;
Frazier et al., 2012; Sanner, Frazier, & Udtha, 2013). Though not a specific study aim, individual
scale analysis showed that the items with the highest mean scores on the BDI-II and PHQ-9 in
this study were somatic symptoms: sleep changes, fatigue & loss of energy, appetite changes,
and loss of interest in sex. The only cognitive symptom with a similarly high mean score was
anhedonia. Changes in thinking regarding depression have led some to recommend more focus
be placed on individual symptoms versus sum scores: individual symptoms may be more
reflective of underlying biology and may also affect the degree of impairment of the individual
(Fried & Nesse, 2015). A recent study by Carney et al. (2018) examining residual depressive
symptoms in the CHD population after treatment with 6-12 sessions of individual cognitive
behavior therapy (CBT) found that loss of energy (69.1% of participants) and fatigue (55.6% of
participants) were the most commonly cited residual symptoms. The third most common, and
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only other symptom to affect >50% of participants post-treatment, was anhedonia (51.6% of
participants). Thus, the feasibility study findings appear to be consistent with other study
findings, but they are also concerning since these women appear to be experiencing the
symptoms that are most resistant to treatment (Carney et al., 2018).
A significant though less robust correlation between ACS and sleep disturbance and
fatigue was also found. These correlations support those found in previous literature on physical
symptoms in CHD (Kohlmann et al, 2013). However, fatigue is a component of the ACS symptom
checklist, so its measurement with this instrument may be redundant (DeVon et al, 2014). For
this reason, a different measure for CHD such as the Duke Coronary Artery Disease Index (Mark,
Nelson, Califf et al., 1994) or a biomarker risk score (Ghasemzedah et al., 2017) may be a better
choice. If this component of the study were to be repeated in the future study, a different
measure for CHD would likely need to be identified.
Several factors have been found in prior research to influence the development of
depressive symptoms in CHD patients. The preliminary results from this study demonstrated
very robust negative correlations between depression scores and participant age. Consistent
with prior research, depression appears to be worse in women who develop CHD at a younger
age (Mallik et al., 2006; Sanner et al., 2013). In this study, the average age of women who met
cut-off criteria for depression on the screening instruments was nearly 20 years younger than
those who did not. At age 46 (the mean age of the younger women in this study), women are
more likely to still be working, may still have children at home, may be caring for grandchildren
and/or be caring for aging parents. A significant change in health status may be quite disruptive
to these women's’ roles and responsibilities, decreasing their ability to provide both tangible
and emotional support to their families. A recent study looking at perceived stress post MI in
young and middle-aged women compared to men found that women had higher stress levels
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initially and over the next 12 months compared to men (Xu et al., 2017). Shah et al.’s (2014)
study examining the association of depression with CHD and adverse cardiac events found a
correlation between depression and CHD and risk of death in women age ≤ 55. These findings
suggest that not only are younger women with CHD struggling, but their lives may be at risk if
they develop clinically significant depression.
The results from this study also demonstrated very robust positive correlation between
depression scores and diabetes. This is also consistent with previous research (Murphy et al.,
2008; Pajak et al., 2013). The correlation between diabetes and depression, even without the
presence of CHD, has been found to be significant (Kanapathy & Bogle, 2019). CHD co-morbidity
with diabetes may be more depressogenic due to the difficulty of managing diabetes and the
mental burden of having two significant chronic medical conditions. The combination of
diabetes, depression, and CHD also puts women at even greater risk of poor outcomes than
diabetes and depression alone (Pan et al., 2011). Research exploring a possible common root
cause for both CHD and diabetes has been a topic of interest, leading to studies of genetic
overlap (Amare, Schubert, Klingler-Hoffmann, Cohen-Woods, & Baune, 2017) as well as
development of systems biological models (Stapelberg, Neumann, Shum, McConnell, &
Hamilton-Craig, 2015). Women experiencing comorbidity with diabetes and CHD will need
significant amounts of education, close follow-up, and both tangible and emotional support. The
importance of exercise in improving diabetes, depression, and CHD needs to be clearly
conveyed.
A history of anxiety also demonstrated a significant correlation to depression scores on
all screening instruments at all timepoints except BDI-II at month 2. Prior research has found
comorbidity of depression and anxiety to be common, particularly in women, and this appears
to be true in the CHD population as well (Sundel, Stain-Mahngren, Andersson, Aberg-Wistedt, &
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Schenck-Gustafsson, 2007; van Montfort, Denollet, Vermunt, Widdershoven, & Kupper, 2017).
Prior studies have also shown a history of anxiety to be a significant predictor of subsequent
depression in CHD patients (Murphy et al., 2014; Schrader, Cheok, Hordacre, & Marker, 2006).
Interestingly, this feasibility study demonstrated a stronger association between a history of
anxiety and current depression than a history of depression and current depression (though
both demonstrated significance at more than one timepoint). This may be a reflection of small
participant numbers, and more participants with a history of anxiety than depression in this
study. A recent scoping review of risk factors for depression in individuals with CHD found a
history of depression to be a stronger predictor of subsequent depression than a history of
anxiety (Greenman et al., 2018). Given the small sample size in this study, results should be
treated as preliminary and interpreted with caution.
This study found a strong correlation between depressive symptom scores and
attendance at cardiac rehabilitation, with women who had higher depression scores attending
cardiac rehabilitation less than those who had lower scores. This is consistent with prior
literature showing that women with greater depressive symptom burden are less likely to
complete cardiac rehabilitation (Sanderson & Bittner, 2005). In a systematic review of studies
examining the effects of exercise on depression in CHD patients, exercise has demonstrated
improvement in depression both in the short and long term in those with increased levels of
depression (Verschueren et al., 2018). Even in women with microvascular disease, a relatively
recently discovered and still poorly understood condition more often affecting women than
men, exercise appears to improve quality of life (Szot, Zając, Kostkiewicz, Owoc, & Bojar, 2015).
This underscores the importance of screening for depressive symptoms prior to discharge so
that women who demonstrate elevated symptoms receive targeted emphasis on the benefits of
attendance for both overall health and improved mood.
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No significant correlation was noted between depression and employment status in this
study. This was an unexpected finding. A recent meta-analysis of observational studies
examining risk factors for post-ACS depression found that “housewife status” was a risk factor
for developing depression whereas being employed was protective (Mei-zhen et al., 2019). This
lack of correlation may be related to the way this question was posed in the survey. Women
were asked if they had held a steady job in the past 6 months – “yes” or “no/retired”. Because
those who are not working by choice (retired) may feel quite different from those who are
involuntarily unemployed, this answer choice may have masked the negative feelings of those
who were unemployed but desired to work. A future study will need to change wording to
ensure that responses separate those who are unemployed by choice from those who are not.
Depressive symptom scores also correlated with ACS symptoms in this study. Angina in
particular has been associated with higher depressive symptom burden in prior studies
(Jespersen, Abildstrom, Hvelplund, & Prescott, 2013; Sundel et al., 2007). A meta-analysis of
studies across 31 countries demonstrated that women were more likely to experience angina
than men (Hemingway et al., 2008). Angina appears to be a more significant problem in those
who do not have “classic” coronary artery disease which is amenable to intervention such as
stenting or bypass (Jespersen, Abildstrom, Hvelplund, & Prescott, 2013). Because nonobstructive disease is more common in women (Pasupathy, Tavella, & Beltrame, 2016), women
appear to be at higher risk of developing associated depression. Evidence-based therapies for
people who experience cardiac ischemia without obstruction (INOCA) are just evolving, and the
Cardiovascular Disease in Women Committee of the American College of Cardiology have
developed an agenda to advance this area (Bairey Merz, Pepine, Walsh, & Fleg, 2017). Follow-up
visits need to include assessment of ongoing ACS symptoms to identify women who may be at
greater risk of developing depressive symptoms.
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Interactions with the health care system are unavoidable for those who have a chronic
illness. Relationships with care providers may either encourage or discourage women from
successfully managing their health. Likewise, financial concerns and insurance coverage issues
may prevent women from following through with important secondary risk reduction such as
cardiac rehabilitation. Social isolation, particularly for women who have lost their spouses or
who do not have family close by, may have a significant negative impact on women’s mental
health. Isolation may be exacerbated if they have experienced a decline in physical health as a
result of their cardiac event. Conversely, interactions with friends and family appear to have a
very positive affect on mental health. Assessing women’s social support following a cardiac
event may be important for determining risk for poor mental health. Finally, women had varied
responses to their health event. Some appeared to feel as if their health was largely unchanged
after their cardiac event. Other women who experienced somatic and/or cognitive symptoms
following their cardiac event seemed to feel that their cardiac event signalled a significant
change in their health. Cultivating a positive relationship with these women will help elicit these
responses and significantly aid in individualizing care.
There does appear to be a relationship between increased depressive symptom burden
and a negative relationship with the health care system, poor perceived social support, and a
perception of changed health status following the cardiac event in this population. While it is
unclear if the depressive symptoms caused these issues or were the result of these issues,
previous research is clear in regards to increased depressive symptom burden leading to worse
health outcomes. Unfortunately, prior research attempting to modify perceived social support
and depression has not yielded significant improvements in morbidity and mortality. The
landmark ENRICHD study, which examined the effects of treatment for low perceived social
support (LPSS) and depression in 2,481 individuals with an acute MI randomized to usual care or
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treatment with cognitive behavioural therapy found improvements in psychosocial outcomes
but no significant difference in “event-free survival” after an average follow-up period of 29
months (Berkman et al., 2003). Since that time, other studies have explored peer support
interventions (Colella & King-Shier, 2018), stress management via group sessions (M. Blom et al.,
2009), and online community building to increase risk-modifying behaviour (Richardson et al.,
2010), with minimal success. Other researchers have looked at the possible effects of depressive
symptom clusters on adherence outcomes (Versteeg, van Montfort, Denollet, & Kupper, 2016)
and the relationships between social strain, social support, quantity of social ties and multisystem risk (via allostatic load) (Seeman, Gruenewald, Cohen, Williams, & Matthews, 2014). The
research community has yet to discover scalable interventions which improve depressive
symptoms, perceived social support, and cardiovascular outcomes.
Strengths and Limitations
One of the strengths of this study is recruitment of women from three different types of
institutions - a large urban public hospital, a large urban private hospital, and a smaller regional
hospital – providing a wide representation of women despite its small size. This study adds
needed granular details regarding depressive experiences of women with CHD over time to the
existing literature. It also provides a preliminary assessment of one of the PROMIS Depression
short form tools in the CHD population. The mixed methods design produced qualitative data
showing that women with higher depressive symptom scores report different experiences post
cardiac event than women who experience fewer depressive symptoms.
There were several limitations to this study. The small sample size limited the statistical
analyses that were possible to perform, particularly estimating an effect size for influence of
CHD and depression on two common overlapping somatic symptoms. Poor uptake of the
qualitative survey limited the available qualitative data available for analysis. The study did not
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assess who was and was not on antidepressant medications and/or undergoing counselling for
depression at the start and during the study. This may have influenced outcomes. The grouping
of retired and unemployed women together may be responsible for the lack of correlation
between depression scores and employment, as those who are unemployed by choice may feel
very differently about their status than those who are not working because they are not able.
Conclusions and Future Recommendations
These study findings suggest that the PROMIS Depression 8b may be an excellent choice
of instrument for those who have significant concerns about measuring somatic symptoms and
wish to choose an instrument that does not contain somatic items since it demonstrated
prevalence similar to BDI-II. Performance of the PROMIS Depression 8b in the female CHD
patient population would benefit from further examination in a larger sample. A dedicated
study examining ROC curves for sensitivity and specificity of the PROMIS Depression 8b versus
other measures containing somatic symptoms compared to diagnostic interview findings in this
population would also be beneficial.
The finding that overall mean depression scores as well as distress scores trended in the
same direction as the somatic symptom scores supports the centrality of somatic symptoms in
women’s experience of depressive symptoms but also suggest that women in particular may be
at increased risk of having residual depressive symptoms, even if they receive appropriate
treatment (Carney et al., 2018). A multi-modality approach may be required to alleviate these
somatic symptoms given the difficulty in treating them to remission with CBT alone (Carney,
2018). The study findings also suggest that ongoing assessment of depressive symptoms in
women in this population is important since depressive symptoms are associated with worse
outcomes (Lichtman et al., 2014). The role of somatic depressive symptoms in this population
needs to continue to be explored. Analysis of individual depressive symptoms to elucidate
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further which specific symptoms are most often reported, by whom, and which remain
unresolved following treatment will aid in development of approaches which can target these
symptoms, preventing persistent depression and potential worse outcomes.
This and other prior research have demonstrated that younger women with CHD
experience much more depression than older women. Studies which elucidate younger
women’s depression risk factors are needed to determine which are amenable to intervention.
Women with comorbid diabetes are another group who clearly demonstrated more depression
in this study than women who do not have diabetes. The co-occurrence of depression in multimorbid individuals is not a unique finding to this study. Because diabetes, depression, and CHD
all respond positively to physical activity, studies comparing different strategies already shown
to promote physical activity in this population should be undertaken.
The strong correlation between baseline depressive symptom scores and attendance at
cardiac rehabilitation has implications for post-discharge care of these cardiac patients. This
relationship suggests that women who are depressed early on after their cardiac event may not
be as attuned to care needs later on in the recovery period. The importance of attending cardiac
rehabilitation needs to be emphasized to women who screen positive for elevated depressive
symptoms either during their hospital stay or at their initial follow-up appointment since these
women appear to be at significant risk of non-attendance.
Intervention studies which address depressive symptoms and low perceived social
support in women with CHD that also improve cardiovascular outcomes and are scalable
continue to be needed. Finally, dedicated efforts to include women and men in equal numbers
in CHD studies and data analysis by gender in all manuscripts from studies which include both
men and women participants need to be priorities in CHD research moving forward if we are to
improve outcomes in women.
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Chapter V.

Conclusion

Discussion
Concept Analysis
The literature on depressive symptoms in women with CHD, though significantly more
substantive since the mid-1990s, continued to demonstrate some important gaps. The concept
of depression in women with CHD itself was problematic, and information regarding what
happens to depressive symptoms in women over time was also lacking. Chapter two of this
dissertation provided a concept analysis of depression in women with CHD, following the steps
laid out by Walker and Avant (Walker & Avant, 2011). The mismatch between the actual
concept and the operational definition of the concept as represented by the depression
screening instruments was discussed. Key attributes of depression in women with CHD were
identified, along with actual and potential antecedents. Finally, the importance of applying
these findings to research and practice was discussed.
Literature Review
Chapter three of the dissertation provided a systematic review of the longitudinal
literature on depressive symptoms in women with CHD. Following PRISMA guidelines, twenty
articles met inclusion criteria for this systematic review. The key findings from this review were
that 35.75% of women experience depression at the time of CHD diagnosis but most appear to
improve over the first 3-6 months. However, this may be a reflection of few studies extending
beyond 6 months. Women also experience more depression than men both at the time of
diagnosis and across time. The instrument used to measure depressive symptoms had a
significant impact on findings, with instruments measuring somatic symptoms yielding
significantly higher prevalence than those that did not (with the exception of results in the
coronary artery bypass graft [CABG] population). The review reinforced that women continue to
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be under-represented in CHD studies and lack of data analysis by gender also continues to be a
gap.
Dissertation Study
Chapter four of the dissertation reported results of the feasibility study examining
depressive symptoms in women with CHD over time. The aims of this study included a)
evaluating the feasibly of enrollment and data collection strategies used in this study, b)
evaluating the quantitative data for preliminary trends, and c) evaluating the qualitative data
collection method and the data generated via this method.
Feasibility Aims
The feasibility aims of this study included evaluating enrollment (recruitment strategies
and efficiency, attrition, problems and solutions) and data collection (use of REDCap vs paper,
instruments reliability, time required, missing data). Recruitment was problematic, due in part
to issues of ethical access to the population. A successful strategy was finally discovered which
minimized time demands for those identifying potential participants, but also required the PI to
be available at the bedside. Prior research has demonstrated that recruitment for research is a
significant problem. A recent review of phases 2 and 3 intervention clinical trials that ended in
2011 and were registered with the National Library of Medicine clinical trial registry found that
19% - nearly 1 in 5 - “either terminated for failed accrual or completed with less than 85%
expected enrolment [sic]” (Carlisle, Kimmelman, Ramsay, & MacKinnon, 2014, p. 77). Very little
data is available on nursing research specifically. An article by Badger and Werrett (2005) out of
the UK examining nursing research published in 2002 in one of three journals (Journal of
Advanced Nursing, Journal of Clinical Nursing, or International Journal of Nursing Studies) found
mean “response rates” of 75%, 74% and 62% for quantitative, qualitative, and mixed methods

115
articles respectively. This author’s experience and the statistics regarding recruitment support
and highlight the importance of feasibility work prior to beginning a fully-powered study.
Attrition was also a problem which was exacerbated by the small number of
participants. Month two, the timepoint with the fewest participants (13), represented a 28%
attrition rate from the 18 who returned baseline surveys (or 41% from the 22 who signed
consent forms) despite the time burden for survey completion being minimal (ave. 20
minutes). According to the literature, the average rate of attrition across all types of clinical
trials is 30% (Lopienski, 2015). Longitudinal studies report attrition rates between 30-70%, with
longer studies generally experiencing greater attrition (Gustavson, von Soest, Karevold, &
Røysamb, 2012). From this perspective a 28% attrition rate is not unusual, though with a small
number of study participants results are much more likely to be impacted. The qualitative
portion of the study demonstrated higher attrition, with only 50% of the original journaling
participants at baseline still submitting journal entries at month three. SmithBattle and
colleagues recently performed a methodological review of 77 qualitative longitudinal nursing
research studies which found that of the 44 studies that reported sample sizes at both the start
and end of the study, 20% experienced 50% attrition (SmithBattle, Lorenz, Reangsing, Palmer,
& Pitroff, 2018). Numerous authors have explored methods to improve recruitment and
minimize attrition, including some which were employed in this study (such as phone calls to
participants, mailing reminders, minimizing study burden, incentive payments), with noted
varying degrees of success (Aitken, Gallagher, & Madronio, 2003; Treweek et al., 2013).
However, it does appear that this author’s challenges with recruitment from these particular
institutions is not unique, as demonstrated by a study by Dr. Weierback, a PhD Neifdelt
Research Fellow at the University of Nebraska Medical Center (2010), where “during 12 months
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of recruitment, 28 individuals consented to participate in the study, and 20 were
interviewed…”(p. 46).
Quantitative Data
Evaluation of the quantitative data for preliminary trends focused on four specific areas
of exploration: prevalence data from three different measurement instruments; changes over
time in depressive symptom dimensions; the influence of CHD and depression on three
overlapping somatic symptoms; and the influence of pre-identified factors on depressive
symptom burden. Findings regarding prevalence were similar to prior research findings at
baseline with a decrease at month two, but remained higher at month three than prevalence
rates in prior studies (Buckland, Pozehl, & Yates, 2019). The role of screening for depression in
the CHD population has been debated ever since the American Heart Association recommended
performing screenings in 2008 (Lichtman et al., 2008), with several authors arguing that it does
not improve outcomes (Thombs et al., 2013; Ziegelstein, Thombs, Coyne, & de Jonge, 2009) and
others arguing that it is financially feasible and does improve depression, which has other
positive ripple effects (Ski et al., 2012; Sowden, Mastromauro, Januzzi, Fricchione, & Huffman,
2010). The results of this study suggest that perhaps screening in certain CHD sub-populations
may be beneficial.
The comparison of instruments in this feasibility study yielded valuable new
information. The PROMIS Depression 8b, a relatively new instrument that has not yet been used
extensively in the cardiac population and does not contain somatic symptoms, was compared to
the BDI-II and PHQ-9 which both contain somatic symptoms. It was expected that the PROMIS
would yield significantly lower prevalence of depression based on previous findings in other
instruments that do not contain somatic symptoms (Buckland et al., 2019). However, the
prevalence for this instrument was comparable to BDI-II and PHQ-9 – an unexpected finding.
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Some authors have argued that including somatic symptoms on depression screening
instruments confuses the clinical picture and makes correct diagnosis more difficult (DeVon,
personal communication, 2014; (Snaith & Zigmond, 1986). Others point to these symptoms as
indicators of potential worse outcomes in CHD patients (de Miranda Azevedo, Roest, Hoen, & de
Jonge, 2014) or as a means of deciphering the underlying CHD from depression (McGuire,
Eastwood, Hays, Macabasco-O'Connell, & Doering, 2014). Given the performance of the PROMIS
Depression 8b in this study, this instrument may provide measures similar to somatic itemcontaining instruments.
Changes over time in depressive symptom dimensions as defined by Lenz et al. in their
Theory of Unpleasant Symptoms (timing, severity, symptom distress, and quality – here, somatic
vs cognitive) showed an interesting trend. Mean scores on the depressive symptom instruments
(severity) and scores on the Subjective Units of Distress scale (distress) demonstrated a decrease
between baseline and month 2 but then showed an increase between months 2 and three,
though the increase in scores were not statistically significant. This pattern was also noted in
changes in somatic depressive symptom scores but not in cognitive symptom scores. Prior
studies have found varying patterns of change in women’s symptom severity over time, though
most appear to improve (Buckland et al., 2019). The fact that overall mean depression scores as
well as symptom distress scores followed the same pattern as somatic symptom scores supports
the centrality of somatic symptoms in women’s experience of depressive symptoms in this
population.
This study proposed to examine the influence of CHD and depression on three
overlapping somatic symptoms: sleep, fatigue, and GI symptoms. There was a very strong
correlation between both depression scores and ACS scores (used as a proxy for CHD in this
study), and sleep and fatigue. Though not a specific study aim, individual scale analysis showed
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that the items with the highest mean scores on the BDI-II and PHQ-9 in this study were somatic
symptoms: sleep changes, fatigue & loss of energy, appetite changes, and loss of interest in sex.
The only cognitive symptom with a similarly high mean score was anhedonia. Changes in
thinking regarding depression have led some to recommend more focus be placed on individual
symptoms versus sum scores: individual symptoms may be more reflective of underlying biology
and may also affect the degree of impairment of the individual (Fried & Nesse, 2015). A recent
study by Carney et al. (2018) examining residual depressive symptoms in the CHD population
after treatment with 6-12 sessions of individual cognitive behavior therapy (CBT) found that loss
of energy (69.1% of participants) and fatigue (55.6% of participants) were the most commonly
cited residual symptoms. The third most common, and only other symptom to affect >50% of
participants post-treatment, was anhedonia (51.6% of participants). Thus, the feasibility study
findings appear to be consistent with other study findings, but they are also concerning since
these women appear to be experiencing the symptoms that are most resistant to treatment.
Weaker correlations were found between depression scores and GI symptom scores over time,
though there was a robust correlation between GI symptom presence at baseline and
depression screening scores across time. More consistent correlations were noted between GI
symptom scores and the corresponding ACS scores across time. The generally weaker
correlations between GI symptoms and depression screening scores may be a result of the poor
reliability of the instrument in this study. It may also be a reflection of symptoms on the scale
not associated with depression, such as lack of taste and nausea. While the ACS symptom
checklist found statistically significant correlations with the three overlapping somatic
symptoms (fatigue, sleep changes, and GI symptoms), this may in fact be a reflection of
measurement redundancy since the ACS symptom checklist contains items related to both
fatigue and GI symptoms.
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The influence of pre-identified factors on depressive symptom burden was also examined in
this study: specifically, the influence of age, diabetes, a history of depression and/or anxiety,
attendance at cardiac rehabilitation, ACS symptoms, and employment status. There was a
strong correlation between age and depressive symptom burden in this study.
Women whose scores on the depression screening instruments met cutoff criteria had a mean
age of 46.25, versus a mean age of 69.38 for those who did not. At age 46, women are more
likely to still be working, may still have children at home, may be caring for grandchildren and/or
be caring for aging parents. A significant change in health status may be quite disruptive to
these women's’ roles and responsibilities, decreasing their ability to provide both tangible and
emotional support to their families. A recent study looking at perceived stress post MI in young
and middle-aged women compared to men found that women had higher stress levels initially
and over the next 12 months compared to men (Xu et al., 2017). Shah et al.’s (2014) study
examining the association of depression with CHD and adverse cardiac events found a
correlation between depression and CHD and risk of death in women age ≤ 55. These findings
suggest that not only are younger women with CHD struggling, but their lives may be at risk if
they develop clinically significant depression.
This feasibility study also found a very strong correlation between depression and a history
of diabetes. The correlation between diabetes and depression, even without the presence of
CHD, has been found to be significant (Kanapathy & Bogle, 2019). The combination of diabetes,
depression, and CHD puts women at even greater risk of poor outcomes than diabetes and
depression alone (Pan et al., 2011). Research exploring a possible common root cause for both
CHD and diabetes has been a topic of interest, leading to studies of genetic overlap (Amare,
Schubert, Klingler-Hoffmann, Cohen-Woods, & Baune, 2017) as well as development of systems
biological models (Stapelberg, Neumann, Shum, McConnell, & Hamilton-Craig, 2015). Women
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experiencing comorbidity with diabetes and CHD will need significant amounts of education,
close follow-up, and both tangible and emotional support. The importance of exercise in
improving diabetes, depression, and CHD needs to be clearly conveyed. Cardiac rehabilitation,
which has been shown to be effective in improving depressive symptoms as well as lowering
cardiac risk (Rutledge, Redwine, Linke, & Mills, 2013) will be particularly important in this group
of patients. Approaches such as behavioral activation, which has been delivered as a manualized
intervention (Ekers, Richards, McMillan, Bland, & Gilbody, 2011; Pasterfield et al., 2014) as well
as on-line (Spates, Kalata, Ozeki, Stanton, & Peters, 2013) may be a viable option to keep
patients motivated following cardiac rehabilitation.
Current depressive symptoms were strongly associated with a history of anxiety in this
study. Prior research has found comorbidity of depression and anxiety to be common,
particularly in women, and this appears to be true in the CHD population as well (Sundel, StainMahngren, Andersson, Aberg-Wistedt, & Schenck-Gustafsson, 2007; van Montfort, Denollet,
Vermunt, Widdershoven, & Kupper, 2017). Prior studies have also shown a history of anxiety to
be a significant predictor of subsequent depression in CHD patients (Murphy et al., 2014;
Schrader, Cheok, Hordacre, & Marker, 2006). Interestingly, this feasibility study demonstrated a
stronger association between a history of anxiety and current depression than a history of
depression and current depression (though both demonstrated significance at more than one
timepoint). This may be a reflection of small participant numbers, and more participants with a
history of anxiety than depression in this study. A recent scoping review of risk factors for
depression in individuals with CHD found a history of depression to be a stronger predictor of
subsequent depression than a history of anxiety (Greenman et al., 2018).
This study found a strong correlation between depressive symptom scores and
attendance at cardiac rehabilitation, with women who had higher depression scores attending
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cardiac rehabilitation less than those who had lower scores. This is consistent with prior
literature showing that women with greater depressive symptom burden are less likely to
complete cardiac rehabilitation (Sanderson & Bittner, 2005). In a systematic review of studies
examining the effects of exercise on depression in CHD patients, exercise has demonstrated
improvement in depression both in the short and long term in those with increased levels of
depression (Verschueren et al., 2018). Even in women with microvascular disease, a relatively
recently discovered and still poorly understood condition more often affecting women than
men, exercise appears to improve quality of life (Szot, Zając, Kostkiewicz, Owoc, & Bojar, 2015).
There was a strong correlation between depressive symptom scores and ACS scores in
this study. ACS symptoms, particularly angina, have been associated with increased depressive
symptom burden in CHD patients in general and women in particular (Jespersen, Abildstrom,
Hvelplund, & Prescott, 2013; Sundel et al., 2007; Trivedi et al., 2015). A meta-analysis of studies
across 31 countries demonstrated that women were more likely to experience angina than men
(Hemingway et al., 2008). Angina appears to be a more significant problem in those who do not
have “classic” coronary artery disease which is amenable to intervention such as stenting or
bypass (Jespersen et al., 2013). Because non-obstructive disease is more common in women
(Pasupathy, Tavella, & Beltrame, 2016), women appear to be at higher risk of developing
associated depression. Evidence-based therapies for people who experience cardiac ischemia
without obstruction (INOCA) are just evolving, and the Cardiovascular Disease in Women
Committee of the American College of Cardiology have developed an agenda to advance this
area (Bairey Merz, Pepine, Walsh, & Fleg, 2017)
No significant correlation was noted between depression and employment status in this
study. This was an unexpected finding. A recent meta-analysis of observational studies
examining risk factors for post-ACS depression found that “housewife status” was a risk factor
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for developing depression whereas being employed was protective (Mei-zhen et al., 2019). This
lack of correlation may be related to the way this question was posed in the survey. Women
were asked if they had held a steady job in the past 6 months – “yes” or “no/retired”. Because
those who are not working by choice (retired) may feel quite different from those who are
involuntarily unemployed, this answer choice may have masked the negative feelings of those
who were unemployed but desired to work. A future study will need to change wording to
ensure that responses separate those who are unemployed by choice from those who are not.
Qualitative Data
Unlike focus groups, individual interviews, or qualitative questions at the end of
quantitative surveys, the use of “purely qualitative” survey as a means of collecting qualitative
data has not been widely used in health care research (Terry & Braun, 2017, p. 17). Little
guidance from the literature exists for qualitative survey as a means of data collection. In his
paper on qualitative survey research, Jansen (2010) describes qualitative survey as “the study of
diversity (not distribution) in a population” (section 2.0, para. 6). According to Jansen (2010)
qualitative surveys may use either open-ended or pre-structured questions, and that “the
qualitative-versus-quantitative nature of data is established in the analysis. It is not inherent
ontology but analysis which determines whether a study is qualitative or quantitative” (section
2.1, para. 3). Terry and Braun (2017) view qualitative surveys as being suitable to answer
questions about people’s experiences, practices, views and perspectives.
Due to concerns about influencing participants because of the longitudinal nature of the
study as well as the fact that objective data was also being collected at the same time, a method
which would generate rich data while minimizing contact with study participants was sought.
Qualitative survey was felt to be a good choice. However, given the longitudinal nature of this
study and the three distinctive writing periods (as opposed to one single period of writing), the
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study would have benefitted from iteratively revising the survey based on the previous survey
content. Participation in the qualitative surveys in this study was poor. This may be due in part
to the fact that the qualitative survey was optional in this study and the PI did not stress the
importance of carrying through with the surveys if participants stated they were interested.
More practical issues also arose, such as participants not being sure what to physically write
“on” (a personal diary, ruled notebook paper, etc). Despite offering to have participants answer
the survey in a word processing program and submit responses electronically, only one
participant chose to use this method. While interesting and useful data was generated in this
study, the use of qualitative survey as a means of qualitative data collection would need to be
significantly improved if it were to be used in a future study and would certainly require a small
pilot study of its own to ensure adequacy of adjustments.
Strengths and Limitations
One of the strengths of this study is recruitment of women from three different types of
institutions - a large urban public hospital, a large urban private hospital, and a smaller regional
hospital – providing a wide representation of women despite its small size. This study adds
needed granular details regarding depressive experiences of women with CHD over time to the
existing literature. It also provides a preliminary assessment of one of the PROMIS Depression
short form tools in the CHD population. The mixed methods design produced qualitative data
showing that women with higher depressive symptom scores report different experiences post
cardiac event than women who experience fewer depressive symptoms.
There were several limitations to this study. The small sample size limited the statistical
analyses that were possible to perform, particularly estimating an effect size for influence of
CHD and depression on three common overlapping somatic symptoms. Poor uptake of the
qualitative survey limited the available quantitative data available for analysis. The study did
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not assess who was and was not on antidepressant medications and/or undergoing counseling
for depression at the start and during the study. This may have influenced outcomes. The
grouping of retired and unemployed women together may be responsible for the lack of
correlation between depression scores and employment, as those who are unemployed by
choice may feel very differently about their status than those who are not working because they
are not able. Finally, the poor reliability of the GI symptom instrument is likely responsible for
the lack of correlation between GI somatic symptom and depression scores. Alternative
measures should be considered in future studies.
Conclusions and Future Recommendations
These study findings suggest that the PROMIS may be an excellent choice of instrument
for those who have significant concerns about measuring somatic symptoms and wish to choose
an instrument that does not contain somatic items since it demonstrated prevalence similar to
BDI-II. Performance of the PROMIS Depression 8b in the female CHD patient population would
benefit from further examination in a larger sample. A dedicated study examining ROC curves
for sensitivity and specificity of the PROMIS Depression 8b versus other measures containing
somatic symptoms compared to diagnostic interview findings in this population would also be
beneficial.
The finding that overall mean depression scores as well as distress scores trended in the
same direction as the somatic symptom scores supports the centrality of somatic symptoms in
women’s experience of depressive symptoms but also suggest that women in particular may be
at increased risk of having residual depressive symptoms, even if they receive appropriate
treatment (Carney et al., 2018). A multi-modality approach may be required to alleviate these
somatic symptoms given the difficulty in treating them to remission with CBT alone (Carney,
2018). The study findings also suggest that ongoing assessment of depressive symptoms in
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women in this population is important since depressive symptoms are associated with worse
outcomes (Lichtman et al., 2014). The role of somatic depressive symptoms in this population
needs to continue to be explored. Analysis of individual depressive symptoms to elucidate
further which specific symptoms are most often reported, by whom, and which remain
unresolved following treatment will aid in development of approaches which can target these
symptoms, preventing persistent depression and potential worse outcomes.
This and other prior research have demonstrated that younger women experience much
more depression than older women. Why this particular group of women is at elevated risk
remains a question. Risk factors need to be elucidated to determine which are amenable to
intervention. Women with comorbid diabetes are another group who clearly demonstrated
more depression in this study than women who do not have diabetes. The co-occurrence of
depression in multi-morbid individuals is not a unique finding to this study. Because diabetes,
depression, and CHD all respond positively to physical activity, studies comparing different
strategies already shown to promote physical activity in this population should be undertaken.
The strong correlation between baseline depressive symptom scores and attendance at
cardiac rehabilitation has implications for post-discharge care of these cardiac patients. This
relationship suggests that women who are depressed early on after their cardiac event may not
be as attuned to care needs later on in the recovery period. The importance of attending cardiac
rehabilitation needs to be emphasized to women who screen positive for elevated depressive
symptoms either during their hospital stay or at their initial follow-up appointment since these
women appear to be at significant risk of non-attendance.
Finally, dedicated efforts to include women and men in equal numbers in CHD studies
and data analysis by gender in all manuscripts from studies which include both men and women

126
participants need to be priorities in CHD research moving forward if we are to improve
outcomes in women.
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APPENDIX A: Longitudinal studies of depressive symptoms in women with CHD
Author & date
1.

Barth et
al., 2009

Bogg
a. et
al., 2000

1

Study purpose
Examine whether
women & men
benefit equally from
outpatient CR1 in
reduction in
psychological
symptoms, &
whether women
show more
impaired
psychological health
at baseline than
men.

• Quasi-experimental,
longitudinal

Assess the influence
of gender on
outcomes after a
cardiac episode.

• Prospective longitudinal
cohort study
Time-points:
• Baseline: 3-4 days post MI
• Time 2: 1 month post MI
• Time 3: 3 months post MI
• Time 4: 6 months post MI

Cardiac rehabilitation
Percutaneous coronary intervention
3
Hospital Anxiety & Depression Scale
2

Study design

Time-points:
• Baseline: 2-4 weeks post
acute event
• Time 2: post-CR

Sample
441 patients:
Women: 89
(20.2%)
Men: 352
(79.8%)
Inclusion:
post acute
coronary
event,
cardiac
decomp.,
PCI2, or heart
surgery
220 patients:
Women: 51
(23%)
Men: 169
(77%)
Inclusion: MI
within 4 days

Depression
scale/other

Results (% or average score  SD)

• Anxiety &
Depression:
German
version of
HADS3

Baseline prevalence of HADS-D7: 15% (no separation
by gender)
• Baseline depression (difference: p=0.29)
o Women: 3.6  3.0
o Men: 3.9  3.5
• Depressive symptoms post CR (p=0.626)
o Women: 3.1 3.2
o Men: 3.1  3.1
o
No age difference between men & women in this study
(unusual)

• Depression:
HADS

Baseline depression (nonsignificant)
• Women: 4.7  3.4
• Men: 4.0  3.2
1 month post MI (p0.01; T=2.68)
• Women: 5.6  3.1
• Men: 4.4  3.9
3 months: ( p0.01; T=2.62)
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of admit,
age<75.

2.

Brink et
al., 2005

Detect changes in
HRQOL over time,
and predict HRQOL
at 1 year based on
measures at 1 week
& 5 months post 1sttime MI.

• Longitudinal descriptive
study
Time-points:
• Baseline: 1 week post MI
• Time 2: 5 months
• Time 3: 1 year

98 patients:
Women: 33
(34%)
Men: 65
(66%)

• Depression:
HADS

3.

CaulinGlaser et
al., 2007

Determine the
effects of
depressive
symptoms & sex on
completion rates in
CR and, in CR
completers,
examine clinical

• Retrospective cohort
analysis

348 patients:
Women: 100
(28.7%)
Men: 248
(71.3%)

• Depressive
symptoms:
BDI-II4

4

Beck Depression Inventory - ll

Time-points:
• Baseline: 4-6 weeks post
hospital discharge
• Time 2: post-CR.

Inclusion:
Enrollment in

(Completion
of CR: >7
weeks’

• Women: 5.9  3.4
• Men: 3.9  3.1
6 months (nonsignificant)
• Women: 4.7  3.0
• Men: 3.9  3.5
Depression was a major predictor of physical quality of
life.
Baseline depression (estimated, based on graphic)
• Women: 2.4
• Men: 2.7
5 months
• Women: 4.1  3.2
• Men: 3.8  3.8
12 months
• Women: 2.8  2.8
• Men: 3.4  3.5
Statistically significant decrease in women between 5
months and 1 year (p0.01)
13% of all respondents scored possible or likely
depression 1 year after MI.
No gender differences at 1 year post MI.
Baseline BDI-ll 14:
• Women: 31%
• Men: 14.5%
53 people/29 women (54.7%) did not complete CR.
• 29 (54.7%) CR non-completers had BDI-II 14 at
baseline.
Pts with baseline BDI-ll 14 had greater symptom
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outcomes.

4.

5.

6.

5
6

Doering et
al., 2006

Duits et
al., 1998

Grace et
la., 2005

a 12-wk CR
program

participation
of 12-week
program)

75 women
• 55 retained
at 6 months

• Depressive
symptoms:
DISH6
• Hx
depression

Describe prevalence
of clinical
depression at 3
timepoints among
women, comparing
frequency of
somatic & affective
symptoms

• Longitudinal descriptive
study

Examine variations
over time in anxiety
& depression in pts
undergoing CABG

• Longitudinal descriptive
study
Time-points:
• Time 1: 2 weeks pre-op
• Time 2: 1 day pre-op
• Time 3: 7 days post-op
• Time 4: 6 months post-op

217 patients:
Women: 41
(19%)
Men: 176
(81%)

• Longitudinal observational
study

913 patients
Women: 323

Examine the
prevalence & course

Time-points:
• Baseline measure: inpatient
• Time 2: 2-4 weeks post
discharge
• Time 3: 6 months

Coronary artery bypass graft
Diagnostic Interview & Structured Hamilton

Inclusion: 1sttime CABG5

• Depression:
HADS

Inclusion:
elective
CABG

• Depression:
BDI

reduction after CR vs. pts with baseline BDI-ll<14
• 14: pre-CR=20.6; post-CR=10.4
• 14: pre-CR=5.8; post-CR=3.5
No statistically significant difference between amount
of change on BDI-II after CR between men & women
Baseline Depressed: 36%
Time 2 Depressed: 16.3%
Time 3 Depressed: 12.7%
• Depressed women were younger (57 vs 64.2)
• More of the depressed women had hx of depression
vs those with no hx of depression (40.7% vs 18.8%)
• Depressed women consistently had higher rates of
fatigue, anhedonia, & dysphoria vs non-depressed
women over the 6-month period.
Time 1
• Women: 7.5  4.7
• Men: 4.7  3.7
Time 3
• Women: 5.4  3.4
• Men: 4.9  3.6
Time 4
• Women: 4.9  4.0
• Men: 3.4  3.5
Both significant time effect, & significant time modified
by gender effects were noted.
BDI ≥10:
Baseline :31.1%.
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7.

8.

7
8

Grace et
al., 2008

GravelyWitte et
al., 2007

of depressive
symptoms x 1 yr
after ACS, & the
effect of CR on this
trajectory

Time-points:

Prospectively assess
changes in
psychosocial health,
comparing women
who participated in
CR with those who
did not.

• Secondary analysis of
prospective, controlled
quasi-experimental design
study
• Baseline (inpatient)
• 18 months

Inclusion:
ACS, PCI, or
CABG.

Examine the impact
of angina and
cardiac hx on
depression and
HRQOL in CHD pts.

• Prospective longitudinal
study
Time-points:
• Baseline: 45 days postcardiac event
• Time 2: 6 months after
baseline

171 patients:
Women: 27
(16%)
Men: 147
(84%)

Myocardial infarction
Unstable angina

• Baseline: inpatient
• Time 2: 6 months
• Time 3: 1 year

(35%)
Men: 590
(65%)
Inclusion: MI7
or UA8

157 women
• 110
retained at
18 months

• Anxiety &
depressive
symptoms:
HADS

Time-points:

@6 mo: 121
Women: 17
(14%)
Men: 104
(86%)

• Depression:
SCL-90

6 months: 25.2%
12 months: 21.7%
• Those with higher BDI scores at 6 months attended
significantly fewer CR sessions than those with lower
BDI scores (p=0.02).
• Depressive symptoms improved for all, regardless of
CR participation.
• Younger participants were more depressed
51 women (45.1%) participated in CR
Baseline: (nonsignificant difference between groups)
• CR: 4.6  3.5
• Non-CR: 5.0  2.8
18 months:
• CR: 4.3  3.7
• Non-CR: 4.1  3.3
Women who did not participate in CR by 18 months
had improvement in depressive symptoms.
Baseline:
• Women no prior CHD: 1.45  0.17
• Men no prior CHD: 1.39  0.14
• Women prior CHD: 1.51  0.11
• Men prior CHD: 1.45  0.13
6 months
• Women no prior CHD: 1.39  0.17
• Men no prior CHD: 1.34  0.13
• Women prior CHD: 1.47  0.11
• Men prior CHD: 1.44  0.13
Cardiac hx not predictive of higher depression levels at
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Inclusion: MI,
PCI, CABG;
age<70.
9.

Gupta et
al., 2007

To see if benefits
from CR are
maintained at 1 yr,
& if there are any
gender-specific
differences.

• Longitudinal descriptive
study

Time-points:
• Baseline: CR entry
• Time 2: 6 months
• Time 3: 1 year

533 patients.
Women: 161
(30.2%)
Men: 372
(69.8%)

• Depression:
BDI-II

244 at 1-yr
• Women: 68
(28%)
• Men: 176
(72.1%))

Inclusion: dx
of CAD9
10.

9

HuntShanks et
al., 2009

Examine
1) Autonomic
anxiety, negative
affect, & depression
over a 2-year period
in cardiac pts.
2) Whether
gender moderated
the exercise/
affective

Coronary artery disease

• Longitudinal descriptive
study

Time-points:
•
•
•
•

Baseline: inpatient
Time 2: 6 months
Time 3: 12 months
Time 4: 24 months

801 patients
Women: 197
(24.5%)
Men: 604
(75.4%)
Inclusion:
Cardiac
patients, but
no unstable

• Depression
& anxiety:
HADS

baseline, but predictive at 6 months.
Women had higher depression levels than men at
baseline.
Depression scores in pts with CHD hx remained stable,
whereas pts with no cardiac hx had improvement.
Baseline
• Women: 9.7
• Men: 9.29
CR completion
• Women: 6.9
• Men: 5.4
1 year
• Women: 7.3
• Men: 5.81
Both men & women showed significant improvement in
depressive symptoms…
• between baseline & end of CR, and
• between baseline & 1 yr
but not between end of CR & 1 yr.
HADS-D7 Baseline:
• Women: 27.9%
• Men: 18.7%
6 months
• Women: 20.6%
• Men: 14.5%
12 months
• Women: 19.2%
• Men: 14.4%
24 months
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relationship
3) Whether
changes in exercise
mediated the
gender/affective
relationship
11.

Josephson
et al.,
2006

Investigate gender
differences in
depressive
symptoms among
cardiac pts in CR.

cardiac
conditions

• Retrospective analysis of
prospectively collected
longitudinal data

Time-points:
• Baseline: Pre-CR
• Time 2: post-CR

402 patients
Women: 113
(28%)
Men: 289
(72%)

• Depressive
symptoms:
BDI

Inclusion:
Cardiac
diagnosis

12.

Lavie &
Milani,
1995

Assess 1) gender
differences post
cardiac event in
baseline exercise
capacity, obesity,
lipids, behavior
characteristics, &
QOL & 2)
improvement
in these after CR.

• Retrospective data review

Time-points:
• Baseline: pre-CR
• Time 2: post-CR

458 people
Women: 85
(18.5%)
Men: 375
(81.8%)
151 post-CR
Women: 31
(20.5%)
Men: 120

• Anxiety,
somatization,
hostility, &
depression:
Kellner
Symptom
Questionnaire

• Women: 19.2%
• Men: 13.3%
Women demonstrated more autonomic anxiety &
depression than men across entire study
Exercise did not mediate any gender/affective relationships
No moderation by gender
BDI10 Baseline:
• Women: 36%
• Men: 22%
Baseline (mean score)
• Women: 8.73  7.68
• Men: 6.44  6.2
Post-CR
• Women: 5.44  5.76
• Men: 4.21  4.76
Pts had significantly higher BDI scores prior to CR
compared to after.
Women showed a larger reduction in BDI scores after
CR than men.
Pts who did not complete CR had higher BDI scores
than those who did complete CR.
Baseline
• Women: 3  4
• Men: 3  5
Post-CR
• Women: 3  5
• Men: 2  4
Depressive symptoms were significantly reduced in
men following CR but not in women.
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(79.5%)

13.

14.

Lavie et
al., 1999

McGrady
et al.,
2009

Investigate the
effects of
depression in
women with
CAD, & assessed the
modulatory effects
of CR & exercise
training programs

• Prospective longitudinal
descriptive study

Determine the
effects of
depression &
anxiety on patient
completion of
structured CR.

• Longitudinal, descriptive,
retrospective chart review

Time-points:
• Baseline: pre-CR (4-5 wks
post cardiac event)
• Time 2: 1 week after CR
completion.

Inclusion:
major
ischemic CAD
event
102 women
• Depressed:
23
• Nondepressed:
79
Inclusion:
CAD dx

Time-points:
• Baseline: start of CR
• Time 2: end of CR

380 subjects
Women: 139
(37%)
Men: 241
(63%)
Inclusion: MI,
CABG,
angina, or
CHF (NYHA
class I or II) or
other (A-fib,
diastolic
dysfunction,
aortic repair,

Depression
cutoff: ≥7

• Anxiety,
somatization,
hostility, &
depression:
Kellner
Symptom
Questionnaire
(Depression
cutoff: ≥7)
• Depression:
BDI-II

Baseline depression ≥7: 22.5%
Post-CR depression ≥7: 12%
• Study supported frequency of depression in women
with CAD.
• Improvement in depressive symptoms following CR.
• Baseline characteristics failed to identify the
depressed women who improved following CR

Baseline (mean)
• Women: 10.9  8.4
• Men: 8.3  7.3
Baseline (BDI-II 10 or BAI15)
• Women: 17.4  6.6
• Men: 20.0  8.1
Post-CR (BDI-II 10 or BAI15 at baseline)
• Women: 10.5  6.2
• Men: 12.9  9.4
Women had overall higher BDI-II scores than men at
baseline.
No statistically significant gender differences in
outcomes post-program.
Significant differences in baseline BDI-II between
completers & dropouts (8.6 vs 11.7, p=0.001)
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15.

Norris et
al., 2007

Examine gender
differences in
specific depressive
symptoms as they
relate to HRQOL
post MI.

• Longitudinal, prospective
cohort study
Time-points:
• Baseline: inpatient
• Time 2: 1 year

heart
transplant)
486 patients
Women: 102
(21%)
Men: 384
(79%)

Younger, female patients had higher dropout rates.
• Depressive
symptoms:
BDI-II

Inclusion:
Admission
through ED
w. dx of AMI
16. qPhillips
Bute et
al., 2003

Examine QOL &
cognitive outcomes
after CABG in men
& women, carefully
adjusting for
baseline differences
& known pre-op risk
factors for poor
outcomes.

• Prospective longitudinal
observational study
Time-points:
• Baseline: inpatient
• Time 2: 1 year

343 pts at
baseline

• Depression:
CES-D

280 at 1 year
No number
breakdown
by gender
Inclusion:
Elective CABG

17.

Sanderson
& Bittner,
2005

Compare baseline
characteristics
between CR
completers & noncompleters; ID
factors associated
w. CR completers;
describe outcomes

• Longitudinal descriptive
study
Time-points:
• Baseline: pre-CR
• Time 1: post-CR

228 women:
• 121 CR
completers
• 107 CR
noncompleters

Inclusion:

• Depression:
BDI-II

Baseline BDI-II 10:
• Women: 40.3%
• Men: 32.7%
1-yr BDI-II10:
• Women: 40.4%
• Men: 31.9%
No significant differences in depression scores between
men & women at baseline.
Women had worsening mean BDI-II scores over the 1st
year post-AMI.
Women more likely to have DM, HTN
Baseline
• Women: 16.95  11.06
• Men: 11.10  9.39
12 months
• Women: 13.91  9.58
• Men: 9.02  8.48
Women’s scores significantly higher than men’s at both
time points.
Women’s recovery not significantly different from
men’s - differences could be attributed to pre-op
differences in depression levels.
Baseline BDI-II≥14: 31%
After CR:
• 67% of women had improved BDI-II scores
• 6% had no change
• 27% had higher scores compared to baseline
_________________________
• 50% of CR non-completers had a BDI-II score >14 vs
16% among completers.
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among CR
completers.

18.

19.

Shin et al.,
2010

Zaninotto
et al.,
2016

Dx of
ischemic
heart disease

Explore gender
differences in the hx
of depression,
depressive
symptoms, & use of
anti-depressants in
pts hospitalized for
ACS & 1-month
post-discharge.

• Prospective longitudinal
design
Time-points:
• Baseline: inpatient
• Time 1: 4 weeks after
discharge

Explore genderspecific changes in
well-being in older
people with CHD vs
those without over
a 6-year period.

• retrospective longitudinal
case-control study
Time-points:
• Baseline: within 2 yrs of a
CHD event
• Time 2: 1 year after baseline
• Time 3: 2 years after
baseline

100 patients
Women: 49
Men: 51

• Depression:
BDI-II
• Hx
depression

1 mo.: 82
Women: 38
Men: 44
Inclusion:
Documented
ACS

895 with
CHD:
Women: 377
Men: 518
3601 w/o
CHD:
Women:
1899
Men: 1702

• Depression:
CES-D8

• CR non-completers were younger, more obese than
completers.
Women who had higher scores after CR than at
baseline still had mean score <14.
BDI-II≥14
Baseline:
• Women: 38.8%
• men=29.4%
1 month:
• women: 26.3%
• men=25%
Hx depression:
• Women: 34.7%
• Men: 17.6%
Taking antidepressants (baseline)
• Women: 38.8%
• Men: 15.7%
___________________
No statistical difference in severity of depressive
symptoms by gender at either time-point.
No improvement from baseline to 1 month
More women than men had hx of depression
Prevalence of depressive “caseness” was higher in CHD
vs healthy group
• For women with CHD, presence of depressive
caseness was constant between baseline and 2-yr f/u,
but 8% lower at 4-yr f/u compared to baseline.
• At baseline & 2-yr f/u, women had 13% higher
probability of depressive caseness vs men.
o This decreased to 5% at 4-yr f/u.
Among CHD pts, depressive caseness was constant over
time among men while women reported
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improvements.
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APPENDIX Q: Original Journaling Guide
Journaling Instructions
The purpose of this journal is to give the researcher (me) a more detailed way to
understand what you are feeling – particularly feelings of depression. People experience
symptoms of depression in many different ways. It may not be clear to you if what you
are feeling is depression or anxiety or anger or even symptoms of your heart disease.
That’s OK. Please include anything that you think will help me understand what you are
feeling.
Please spend at least 15 minutes a day, at least 3 out of the next 7 days, writing in
this journal. The following list contains examples of the kinds of things I hope you will
comment on/write about.
1. The timing of your depressive symptoms
• Have you noticed that your emotions/mood changes with the time of day, or
during certain parts of the week?
• Do your emotions change (improve or get worse) with certain activities, and if
so what are those activities?
• Have you noticed a “trend” in your mood overall – either improvement or
decline?
2. The severity of your depressive symptoms
• If you have noticed a certain feeling (for example, fatigue or trouble
concentrating), has it been mild/minor or has it been rather
significant/severe?
• Have you noticed if anything in particular seems to change the severity of
your symptoms (either for better or worse)?
3. The distress caused by your depressive symptoms
• How bothered or distressed by your mood/feelings have you been?
4. The quality of your depressive symptoms
• What “cognitive” (emotional) symptoms have you been experiencing (such as
feeling down or not being interested in doing anything)?
• What “somatic” (physical) symptoms have you been experiencing (such as
fatigue or poor appetite) that you think are related to your feelings rather than
your heart disease?
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APPENDIX R: Revised Journaling Guide
Journaling Instructions
The purpose of this journal is to give the researcher (me) a more detailed way to
understand what you are feeling, particularly in regards to your mood/emotions. People
experience many different feelings after they are diagnosed with a chronic illness such
as coronary heart disease. It may not be clear to you if what you are feeling is
depression or anxiety or anger or even symptoms of your heart disease (as things like
fatigue and poor sleep can be mood-related as well as disease-related). That’s OK.
Please include anything that you think will help me understand what you are feeling.
Please spend at least 15 minutes a day, at least 3 out of the next 7 days, writing in
this journal. The following list contains examples of the kinds of things I hope you will
comment on/write about.
5. The timing of your feelings/mood changes
• Have you noticed that your emotions/mood changes with the time of day, or
during certain parts of the week?
• Does your mood change (improve or get worse) with certain activities, and if
so what are those activities?
• Have you noticed a “trend” in your mood overall – either improvement or
decline?
6. The “severity” of your feelings/mood
• If you have noticed a certain mood, has it been mild/minor or has it been
rather significant/severe?
• Have you noticed if anything in particular seems to change the severity of
your feelings (either for better or worse)?
7. The distress caused by your feelings
• How bothered or distressed by your mood/feelings have you been?
8. The quality of your feelings/mood
• What “cognitive” (thinking/brain) symptoms have you been experiencing
(such as feeling down or not being interested in doing anything)?
• What “somatic” (physical/body) symptoms have you been experiencing (such
as fatigue or poor appetite) that you think are related to your feelings rather
than your heart disease?

